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A B S T R A C T
Fipronil is described as a thyroid disruptor in rat. Based on the hypothesis that this results from a
perturbation of hepatic thyroid hormone metabolism, our goal was to investigate the pathways involved
in ﬁpronil-induced liver gene expression regulations. First, we performed a microarray screening in the
liver of rats treated with ﬁpronil or vehicle. Fipronil treatment led to the upregulation of several genes
involved in the metabolism of xenobiotics, including the cytochrome P450 Cyp2b1, Cyp2b2 and Cyp3a1,
the carboxylesterases Ces2 and Ces6, the phase II enzymes Ugt1a1, Sult1b1 and Gsta2, and the
membrane transporters Abcc2, Abcc3, Abcg5, Abcg8, Slco1a1 and Slco1a4. Based on a large overlap with
the target genes of constitutive androstane receptor (CAR) and pregnane X receptor (PXR), we postulated
that these two nuclear receptors are involved in mediating the effects of ﬁpronil on liver gene expression
in rodents. We controlled that liver gene expression changes induced by ﬁpronil were generally
reproduced in mice, and then studied the effects of ﬁpronil in wild-type, CAR- and PXR-deﬁcient mice.
For most of the genes studied, the gene expression modulations were abolished in the liver of PXR-
deﬁcient mice and were reduced in the liver of CAR-deﬁcient mice. However, CAR and PXR activation in
mouse liver was not associated with a marked increase of thyroid hormone clearance, as observed in rat.
Nevertheless, our data clearly indicate that PXR and CAR are key modulators of the hepatic gene
expression proﬁle following ﬁpronil treatment which, in rats, may contribute to increase thyroid
hormone clearance.
 2013 The Authors. Published by Elsevier Inc. 
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Open access under CC BY-NC-SA license.1. Introduction
The broad-spectrum phenylpyrazole insecticide ﬁpronil (5-
amino-1-(2,6-dichloro-4-(triﬂuoromethylphenyl)-4-(triﬂuoro-
methylsulﬁnyl)pyrazole-3-carbonitrile,CAS:120068-37-3) is widelyAbbreviations: Abc, ATP-binding cassette; CAR, constitutive androstane receptor; Ces, car
triiodothyronine; FT4, free thyroxine; GABA, g-aminobutyric acid; GEO, gene expres
quantiﬁcation; MRM, multiple reaction monitoring; MRP, multidrug resistance-associat
pregnenolone-16alpha-carbonitrile; Polr2a, RNA polymerase II polypeptide A; PXR, pre
chain reaction; Slco, solute carrier organic anion transporter; Sult, sulfotransferase; T
stimulating hormone; TT3, total triiodothyronine; TT4, total thyroxine; Ugt, 50-diphosp
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fax: +33 5 61 28 52 44.
E-mail address: Pascal.Martin@toulouse.inra.fr (Pascal G.P. Martin).
0006-2952 2013 The Authors. Published by Elsevier Inc. 
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Open access under CC BY-NC-SAused in granular turf products, seed treatments, topical pet care
products, gel baits and liquid termiticides in many countries
leading to a high rate of potential contamination of the human
domestic environment. It belongs to the second generation of
insecticides acting at the g-aminobutyric acid (GABA) receptor asboxylesterase; Cyp, cytochrome P450; ESI+, electrospray ionization mode; FT3, free
sion omnibus; GO, gene ontology; Gst, glutathione S-transferase; LOQ, limit of
ed protein; OATP, organic anion-transporting polypeptide; PB, phenobarbital; PCN,
gnane X receptor; QC, quality control; RT-qPCR, real-time quantitative polymerase
3, triiodothyronine; T4, thyroxine; Tbp, TATA-box binding protein; TSH, thyroid-
ho (UDP)-glucuronosyltransferase.
artin-du-Touch, BP 93173, 31027 Toulouse Cedex 3, France. Tel.: +33 5 61 28 55 24;
 license.
B.B. Roques et al. / Biochemical Pharmacology 86 (2013) 997–1039998a noncompetitive blocker of the GABA-gated chloride channel [1].
It was developed as a substitute for the ﬁrst generation of
insecticidal chloride channel blockers such as the chlorinated
cyclodienes and other polychlorocycloalkanes based on its
selective toxicity for insects [2], thus lowering the risk for human
health.
However, ﬁpronil does not act only on the central nervous
system (CNS). Regulatory toxicological evaluations and experi-
mental investigations have shown that ﬁpronil can act as a thyroid
disruptor as it decreases plasma thyroid hormone concentrations
in rats [3–5]. Because thyroid hormones regulate important
biological processes including bone growth and development,
cardiac function, CNS development, thermogenesis and hepatic
metabolism [6], it is critical to understand the mechanisms
underlying the thyroid disrupting effects of ﬁpronil and their
potential relevance to humans. From previous studies, we know
that ﬁpronil treatment of rats is associated with a marked increase
in the clearance of free and total thyroxine (T4) resulting, at least in
part, from an increase in the activity and mRNA expression of two
types of phase II hepatic enzymes potentially involved in T4
elimination, the uridine 50-diphospho (UDP)-glucuronosyltrans-
ferases (UGT) and the sulfotransferases (SULT) [4,5]. Moreover, the
main ﬁpronil metabolic pathway, leading to ﬁpronil sulfone
formation, is mediated by hepatic cytochrome P450 (CYP) enzymes
[7] which are induced in the liver by ﬁpronil treatment [5]. Upon
exposure to xenobiotics, the increased expression and activity of
hepatic enzymes involved in the metabolism of both xenobiotics
and endogenous compounds often results from the activation of
‘‘xenosensors’’ such as the constitutive androstane receptor (CAR)
and the pregnane X receptor (PXR). These two nuclear receptors
have been shown to regulate the expression of overlapping sets of
genes including hepatic phase I enzymes such as CYP2B and CYP3A
[8] as well as phase II enzymes [9,10] and membrane transporters
[11,12] involved in hepatic xenobiotic and thyroid hormone
metabolism. Additionally, ﬁpronil has been shown to be a ligand of
the human PXR in vitro [13].
Based on this information and on a screening of the impact of
ﬁpronil on the rat liver transcriptome presented here, we
hypothesized that CAR and/or PXR could mediate the impact of
ﬁpronil on hepatic thyroid hormone metabolism in rodents. Based
on this hypothesis, the goals of this study were: (1) to document
the changes in liver gene expression proﬁle occurring in rats
treated with doses of ﬁpronil which induce an increase of thyroid
hormone clearance, (2) to identify a set of mouse hepatic
transcripts regulated by ﬁpronil in the same manner as in rat,
(3) to evaluate in CAR-deﬁcient and PXR-deﬁcient mouse models
the contributions of these receptors to the modulation of hepatic
gene expression induced by ﬁpronil and (4) to determine if the
expression of these receptors was required for ﬁpronil metabolism
and ﬁpronil-induced increase of thyroid hormone clearance.
2. Materials and methods
2.1. Animals and treatments
Female Wistar rats (Charles River, L’Abresle, France) and wild-
type C57BL/6J male mice (Janvier, Le Genest St Isle, France) were
acclimatized for at least 2 weeks to housing conditions (22  2 8C,
12 h light/dark cycle, free access to water and food: A04 diet, Safe,
Augy, France). Female rats were chosen for gene expression studies
because the effect of ﬁpronil on thyroid hormone clearance has been
best described in this gender [4,5]. On the other hand, we used male
mice for pharmacokinetic and gene expression studies because (i)
most published studies on CAR/PXR activation by xenobiotics have
been performed in male mice and (ii) we wanted to avoid the
potentially confounding effect of the estrous cycle in the mousepharmacokinetic study. This latter point is more critical for the mouse
than for the rat pharmacokinetic study because only a single blood
sample can be obtained from each mouse for the estimation of the
labeled T4 clearance. In vivo studies were conducted under E.U.
guidelines for the use and care of laboratory animals. CAR/ [14]
and PXR/ [11] male mice on a C57BL/6J genetic background are a
generous gift from Pr David Moore (Baylor College of Medicine,
Houston, TX, USA) and Pr Steven Kliewer (University of Texas
Southwestern Medical School, Dallas, TX, USA) respectively. Colony
founders were kindly provided by Pr Urs A Meyer (Biozentrum,
University of Basel, Basel, Switzerland). Fipronil (95.6% purity, 3B
Medical Systems, Libertyville, IL, USA) was administered orally as a
suspension through feeding needles, daily for 14 days. Control
animals received the vehicle alone (methylcellulose 0.5% (w/v) and
Tween 80 0.01% (w/v) for rats and Arabic gum 3% (w/v) for mice). All
administrations were performed under a volume of 2 mL/kg of body
weight for rats and 2.5–3 mL/kg of body weight for mice. To evaluate
T4 clearance, adult male mice from the different genotypes were
administered an intraperitoneal (ip) bolus (10.2 mg/kg) of levothyr-
oxine labeled with a stable isotope (13C6-LT4, Isosciences, King of
Prussia, PA, USA) dissolved in 10 mM PBS pH = 7.4 containing 0.1% (w/
v) bovine serum albumin. The following four different animal
experiments were performed:
1. Two- to three-month-old female Wistar rats (202.4  6.0 g body
weight) treated with ﬁpronil (3 mg/kg per day) or not were used
for microarray (n = 7–8 per group) and qPCR liver gene expression
studies (n = 10–14 per group including the animals used for the
microarray study).
2. Nine-week-old male C57BL/6J mice (23.3  0.9 g body weight)
treated with ﬁpronil (5 mg/kg per day) or not (n = 8 per group)
were used for qPCR gene expression studies.
3. Fifteen to 22-week-old male C57BL/6J wild-type (30.7  2.1 g
body weight), CAR/ (32.4  4.2 g body weight) and PXR/
mice (29.4  3.4 g body weight) treated with ﬁpronil (3 mg/kg per
day) or not were used to estimate 13C6-LT4 clearance (n = 5 mice/
genotype/treatment for 0.25 and 4 h and n = 10 mice/genotype/
treatment for 2, 8, 12 and 24 h) and for qPCR gene expression
studies (n = 5 mice/genotype/treatment).
4. Nine-week-old male C57BL/6J wild-type (25.7  1.2 g body
weight), CAR/ (26.3  2.1 g body weight) and PXR/ mice
(26.3  2.1 g body weight) treated with ﬁpronil (10 mg/kg per day)
or not were used for qPCR gene expression studies.
Plasma parameters such as ﬁpronil and ﬁpronil sulfone, thyroid
hormones or TSH were also obtained from these different studies
as described throughout the manuscript.
2.2. Blood and tissue samples
Blood samples were collected in heparinized tubes by aortic
puncture following euthanasia (rats) or intracardiac puncture under
isoﬂurane anesthesia (mice). Plasma was prepared by centrifugation
(4000  g, 15 min, +4 8C) and stored at 20 8C until use. Following
euthanasia, the liver was promptly removed, weighted, rinsed in ice-
cold saline solution, dissected (100 mg fragments), snap-frozen in
liquid nitrogen and kept at 80 8C until use.
2.3. Gene expression studies by RT-qPCR and microarrays
Total RNA was extracted using TRIzol reagent (Life Technologies,
Saint Aubin, France). For real-time quantitative polymerase chain
reaction (qPCR), 2 mg of total RNA were reverse transcribed with the
High Capacity cDNA reverse transcription kit (Life Technologies,
Saint Aubin, France). Ampliﬁcations with speciﬁc primers (Table 1)
and SYBR Green ﬂuorescence monitoring (Power SYBR Green PCR
Table 1
Primers used in real-time qPCR experiments.
Gene DNA sequences Forward primer (50-30) Reverse primer (50-30)
Rat primers
Tbp NM001004198 ccacaccagcctctgagagc agccaagattcacggtggat
Polr2a XM002727723 cggcgtcctgagtccg aacttgggggactaatggatcc
Car NM022941 gagtataaacagcgcatactcatatgaaa ctgggcctcagctgcaa
Pxr NM052980 aggacacgcacccctttg ccgtccgtgctgctgaat
Cyp2b1 NM001134844 gcactgaaaaagagtgaagctttc ggaacaattcatttcgggca
Cyp2b2 NM01198676 ctccgctatggtttcctgct agggatggtggcctgtga
Cyp3a1 NM013105 ttctgcaaaacttctccttccag ctttagaataatgggttttgttggttg
Ces2 NM001044258 gaaacaaattcacgctcggc gcccagtatctggcctgtgt
Ces6 NM144743 ctctgataaatctgaggtggtctacaag catccagataggttggctactgtctt
Ugt1a1 NM012683 cttcagaaaaaagccctatccca ccaaagagaaaaccacgatgc
Sult1b1 NM022513 gaacaaaatgttcctggagcaag tgatggagttttcttcaagagttcaa
Gsta2 NM017013 ggtaatatgtcccccagaccaa ccgggtcagcctgttacct
Abcc2 NM012833 cccattatccgtgcctttga tccagccgaattgcaagc
vAbcc3 NM080581 gggagctgggctccaagt ggaacccaggccagcaa
Abcg5 NM053754 tctccttgtacatcgagagtggc cgtccagcagcgtggttt
Abcg8 NM130414 accaactgtggaactgctgct ccggaagtcattggaaatctg
Slco1a1 NM017111 agattagacttctcactcctgtgtcatt taataacctgattaagtttgtcagtgctc
Slco1a4 NM131906 aactttcctattgcagaaatatcatttaga tgcagaggataaatcaaaacaaactaac
Cyp4a1 NM175837 ccactatgacattctgaaaccctatgta tgccagctgttcccatttg
Cd36 NM031561 ggaggcattctcatgccg tgaaagcaatggttccttcttca
Hmgcs2 NM173094 caacgctgccaactggatg gggcgttaccacttgggtaga
Thrsp NM012703 tccatcacatccttacccacc gggtcctcatcgtcttccct
Mouse primers
Tbp NM013684 acttcgtgcaagaaatgctgaa gcagttgtccgtggctctct
Polr2a NM009089 aagagagtgcagttcggagtcct tccgttgtttctgggtatttga
Car NM009803 gctgcaagggcttcttcaga ccttccagcaaacggacaga
Pxr NM010936 agagatcatccctcttctgccac gatctggtcctcaataggcaggt
Cyp2b10 NM009999 tttctgcccttctcaacaggaa atggacgtgaagaaaaggaacaac
Cyp3a11 NM007818 tcacacacacagttgtaggcagaa gtttacgagtcccatatcggtagag
Ces2c NM145603 cgggctgctgcttcttcttat ctgtatgtgtgtttctgatggggt
Ces2a NM001190330 tcctgctgtgacactctcatgtg ccaaccaggaagtctagccaa
Ugt1a1 NM201645 tcagagaactttatgtgcagagtggt catgctccccagaggcg
Sult1b1 NM019878 ggtgacattgtaataaccacttaccct ggtgataacatctctcttacatttttcaac
Gsta2 NM008182 cacactcctctggagctggat cccgggcattgaagtagtga
Abcc2 NM013806 cctgaatctcacgcgccta cagatggagtccagacatgctg
Abcc3 NM029600 tcttgctgataccactcaatgga gcgggagtccttgaacttcat
Abcg5 NM031884 tcgccacggtcattttca gccaaaagagcagcagagaaata
Abcg8 NM026180 atccattggccacccttgt gcgtctgtcgatgctggtc
Slco1a1 NM013797 gttgcaacacaagaaggcagatt atttggctaggtatgcacatgttaat
Slco1a4 NM030687 tatggaaaatccactgctgagatagtc aatcaaaccaccaattaaatatccg
Cyp4a10 NM010011 attagtgagagtgaggacagcaacag tgtctgcaaatcgggttgg
Cd36 NM007643 gttaaacaaagaggtccttacacatacag cagtgaaggctcaaagatggc
Hmgcs2 NM008256 tgcaggaaacttcgctcaca aaatagacctccagggcaagga
Thrsp NM009381 aacggaggaggccgaagaag gttgatgcacctcggggtct
Cyp2c29 NM007815 gctcaaagcctactgtca catgagtgtaaatcgtctca
Cyp4a14 NM007822 tcagtctatttctggtgctgttc gagctccttgtccttcagatggt
Sult1c2 NM026935 aatggtgatgtagagaagtgccg ggaagatgggtccttaatatccttg
Sult1d1 NM016771 gatgacattttgatctccacatatcc cccattgttgtagatcaaatccagta
Sult1e1 NM023135 atttcacttcttccacgggaac ccaaaaacttcataatactcaggcatag
Ugt1a2 NM201645 tccttcctcttatattccgaacctac gaaaacaacgatgccatgctc
Ugt1a6 NM145079 gctacctagaggcacaggtctctaac aagtgtctgagcagcaggaagaa
Ugt1a9 NM201644 aagaacatgcattttgctcctactt tctgtcatagtcactggggtctga
Ugt2b1 NM152811 gttttctctgggatcaatggttaaa tttcttaccatcaaatctccacagaac
Ugt2b5 NM009467 ccattgcaaacctgctaaacc actaaccattgacccaagagaaaaga
Abcb1a NM011076 catgacagatagctttgcaagtgtag ggcaaacatggctcttttatcg
Slco1b2 NM020495 gacaaggcactgcgatgga gccttgcatatgtagctgaatga
Dio1 NM007860 ctttgcctccacagccga acgttgttcttaaaagcccagc
Dio3 NM172119 tttagatttcttgtgcatccgc ttcgggctcagggtggt
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performed on a Viia7 instrument (Life Technologies, Saint Aubin,
France). qPCR data were normalized by the geometric mean of TATA-
box binding protein (Tbp) and RNA polymerase II polypeptide A
(Polr2a) mRNA levels and analyzed using the 2-DCt method.
Microarray data were obtained from 1 mg of hepatic total RNA
labeled with Cy3 using One-Color Quick Amp Labeling kit (Agilent,
Massy, France) and hybridized to Agilent Whole Rat Genome
microarrays (4x44K) following the manufacturer’s instructions. All
experimental details are available in the Gene Expression Omnibus
(GEO) database under accession GSE39378.2.4. Fipronil and ﬁpronil sulfone assay
In rats, plasma ﬁpronil and ﬁpronil sulfone concentrations were
determined by HPLC coupled with a UV/MS detection method as
previously described [15]. In mice, the extraction method was
unchanged but ﬁpronil and ﬁpronil sulfone plasma concentrations
were assayed by LC/MS with an Acquity ultra performance liquid
chromatography (UPLC1) coupled to a Xevo1 triple quadrupole
mass spectrometer (Waters, Milford, MA, USA). The mean within
and between day precisions were below 15% for both ﬁpronil
(three different quality controls (QC) pools) and ﬁpronil sulfone
B.B. Roques et al. / Biochemical Pharmacology 86 (2013) 997–10391000(ﬁve different QC pools) for the two methods. The limit of
quantiﬁcation (LOQ) was 2.5 ng/mL for both ﬁpronil and ﬁpronil
sulfone.
2.5. Thyroid hormone assays
Total T4, free T4, total T3 and free T3 plasma concentrations
were determined using radioimmunoassay kits from Siemens
(Coat-a-count1 kit, Siemens Healthcare Diagnostics, Los Angeles,
CA, USA). TSH plasma concentrations were determined using
radioimmunoassay kits from Biocode-Hycel (Massy, France). All
the assays were performed according to the manufacturer’s
instructions. For all assays, the mean within and between day
precisions for QC pools were below 15%. The limits of quantiﬁca-
tion for the total T4 and the total T3 assays were validated at 5 ng/
mL and 0.2 ng/mL, respectively. The limits of detection of the free
T4, the free T3 and the TSH assays were set at the lowest value of
the standard curves, i.e. 1 pg/mL, 0.52 pg/mL and 2.1 ng/mL,
respectively.Fig. 1. Plasma concentrations of ﬁpronil and ﬁpronil sulfone and thyroid hormone proﬁle
and ﬁpronil sulfone (dark gray) concentrations were assayed in plasma samples from fem
free T4, total T3, free T3 (B) and TSH (C) concentrations were assayed in plasma samples fr
or the vehicle alone (white bars, n = 14). Signiﬁcantly different from the vehicle group13C6-LT4 was assayed by LC/MS with UPLC
1 coupled to a Xevo1
triple quadrupole mass spectrometer. Samples spiked with T4-d5 as
an internal standard were puriﬁed by solid phase extraction (SPE)
with Strata X-C cartridges (Phenomenex, LePecq, France). The
extracted samples were separated on an Acquity BEH1 RPC18
column (2.1 mm  100 mm, 1.7 mm, Waters, Milford, MA, USA) with
an acidiﬁed (0.05% formic acid) H2O/AcN gradient elution. Samples
were ionized in positive electrospray ionization mode (ESI) and
detected with the multiple following reaction monitoring (MRM)
transitions: 13C6-LT4 m/z 784 < 738 and T4-d5 m/z 783 < 201. The
mean within and between day precisions of three QC pools were
below 15%. The calibration curve ranged from 0.2 to 100 ng/mL.
2.6. Pharmacokinetic analysis
The pharmacokinetic analysis following 13C6-LT4 injection was
performed by least-square regression analysis using WinNonlin1
software (WinNonlin1 5.3, Pharsight Corporation, CA, USA). The
time course of plasma 13C6-LT4 concentrations were ﬁtted using as in rat treated with 3 mg/kg per day of ﬁpronil for 14 days. (A) Fipronil (light gray)
ale rats treated with ﬁpronil (3 mg/kg per day for 14 days, n = 10). (B and C) Total T4,
om female rats treated with ﬁpronil (black bars, 3 mg/kg per day for 14 days, n = 10)
: **p < 0.01.
Table 2
Genes signiﬁcantly upregulated in rat liver following ﬁpronil treatment (q-value < 0.1).
ProbeName GeneName SystematicName log2(FIP/CTRL) p-value q-value Description




A_43_P12924 Abcg5 NM_053754 3.43 0.0000 0.0000 refjRattus norvegicus ATP-binding
cassette, subfamily G (WHITE), member
5 (Abcg5), mRNA [NM_053754]
A_44_P102588 Ces2c NM_133586 2.76 0.0000 0.0000 refjRattus norvegicus carboxylesterase
2C (Ces2c), mRNA [NM_133586]
A_44_P242938 Ces2a NM_144743 2.56 0.0000 0.0000 refjRattus norvegicus carboxylesterase
2A (Ces2a), mRNA [NM_144743]
A_44_P421809 Ugt2a3 NM_001135869 2.46 0.0000 0.0000 refjRattus norvegicus UDP
glucuronosyltransferase 2 family,
polypeptide A3 (Ugt2a3), mRNA
[NM_001135869]
A_44_P203532 Slco1a4 NM_131906 2.45 0.0000 0.0000 refjRattus norvegicus solute carrier
organic anion transporter family,
member 1a4 (Slco1a4), mRNA
[NM_131906]
A_42_P708480 Slco1a4 NM_131906 2.31 0.0000 0.0000 refjRattus norvegicus solute carrier
organic anion transporter family,
member 1a4 (Slco1a4), mRNA
[NM_131906]
A_43_P16529 Gadd45b NM_001008321 2.22 0.0000 0.0000 refjRattus norvegicus growth arrest and
DNA-damage-inducible, beta
(Gadd45b), mRNA [NM_001008321]
A_44_P446578 Ugt1a1 NM_012683 2.08 0.0000 0.0000 refjRattus norvegicus UDP
glucuronosyltransferase 1 family,
polypeptide A1 (Ugt1a1), mRNA
[NM_012683]
A_42_P813567 Scd NM_031841 2.01 0.0038 0.0929 refjRattus norvegicus stearoyl-CoA
desaturase (delta-9-desaturase) (Scd),
mRNA [NM_031841]
A_44_P541213 LOC681383 NM_001109441 1.99 0.0000 0.0001 refjRattus norvegicus similar to Protein
C10orf11 homolog (LOC681383), mRNA
[NM_001109441]
A_44_P320677 Slco1a6 NM_130736 1.95 0.0000 0.0000 refjRattus norvegicus solute carrier
organic anion transporter family,
member 1a6 (Slco1a6), mRNA
[NM_130736]
A_44_P311322 Cyp2b2 NM_001198676 1.94 0.0000 0.0046 refjRattus norvegicus cytochrome P450,
family 2, subfamily b, polypeptide 2
(Cyp2b2), mRNA [NM_001198676]
A_42_P679814 Cyp3a18 NM_145782 1.89 0.0000 0.0000 refjRattus norvegicus cytochrome P450,
family 3, subfamily a, polypeptide 18
(Cyp3a18), mRNA [NM_145782]
A_44_P109562 Akr1c13 NM_001014240 1.79 0.0008 0.0520 refjRattus norvegicus aldo-keto
reductase family 1, member C13
(Akr1c13), mRNA [NM_001014240]
A_44_P1046787 Rpesp XM_001063197 1.68 0.0000 0.0115 refjPREDICTED: Rattus norvegicus RPE-
spondin (Rpesp), mRNA
[XM_001063197]
A_44_P126355 Rbm38 NM_001108965 1.66 0.0001 0.0180 refjRattus norvegicus RNA binding
motif protein 38 (Rbm38), mRNA
[NM_001108965]
A_44_P402641 Ugt1a2 NM_201423 1.64 0.0000 0.0000 refjRattus norvegicus UDP
glucuronosyltransferase 1 family,
polypeptide A2 (Ugt1a2), mRNA
[NM_201423]
A_43_P23115 Inmt NM_001109022 1.58 0.0000 0.0051 refjRattus norvegicus indolethylamine
N-methyltransferase (Inmt), mRNA
[NM_001109022]
A_44_P311323 Cyp2b2 NM_001198676 1.58 0.0001 0.0162 refjRattus norvegicus cytochrome P450,
family 2, subfamily b, polypeptide 2
(Cyp2b2), mRNA [NM_001198676]
A_44_P209854 FQ077343 FQ077343 1.58 0.0001 0.0201 gbjFQ077343 Rattus norvegicus brain
Sprague–Dawley Rattus norvegicus
cDNA 30 , mRNA sequence [FQ077343]
A_44_P470794 Abcg8 NM_130414 1.57 0.0000 0.0001 refjRattus norvegicus ATP-binding
cassette, subfamily G (WHITE), member
8 (Abcg8), mRNA [NM_130414]
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Table 2 (Continued )
ProbeName GeneName SystematicName log2(FIP/CTRL) p-value q-value Description
A_44_P200539 Cbll1 NM_001108018 1.47 0.0021 0.0763 refjRattus norvegicus Cas-Br-M
(murine) ecotropic retroviral
transforming sequence-like 1 (Cbll1),
mRNA [NM_001108018]
A_44_P828941 TC596530 TC596530 1.42 0.0000 0.0016 Unknown
A_44_P372277 Ugt2b1 NM_173295 1.41 0.0000 0.0000 refjRattus norvegicus UDP
glucuronosyltransferase 2 family,
polypeptide B1 (Ugt2b1), mRNA
[NM_173295]
A_44_P432355 Ugt1a2 NM_201423 1.38 0.0000 0.0000 refjRattus norvegicus UDP
glucuronosyltransferase 1 family,
polypeptide A2 (Ugt1a2), mRNA
[NM_201423]
A_44_P313452 Spink1 NM_152936 1.37 0.0015 0.0666 refjRattus norvegicus serine peptidase
inhibitor, Kazal type 1 (Spink1), mRNA
[NM_152936]
A_44_P113879 Slco1a5 NM_030838 1.35 0.0000 0.0000 refjRattus norvegicus solute carrier
organic anion transporter family,
member 1a5 (Slco1a5), mRNA
[NM_030838]
A_43_P19879 LOC689770 NM_001142304 1.30 0.0012 0.0599 refjRattus norvegicus similar to
osteoclast inhibitory lectin
(LOC689770), mRNA [NM_001142304]
A_44_P156850 Akr1c12l1 NM_001135744 1.25 0.0006 0.0452 refjRattus norvegicus aldo-keto
reductase family 1, member C12-like 1
(Akr1c12l1), mRNA [NM_001135744]
A_44_P365286 Aldh1a1 NM_022407 1.22 0.0000 0.0121 refjRattus norvegicus aldehyde
dehydrogenase 1 family, member A1
(Aldh1a1), mRNA [NM_022407]
A_44_P967547 FQ161612 FQ161612 1.18 0.0007 0.0473 gbjFQ161612 Rattus norvegicus spleen
Sprague–Dawley Rattus norvegicus
cDNA clone TL0AEA25YG21 30 , mRNA
sequence [FQ161612]
A_44_P1002360 Cryl1 NM_175757 1.18 0.0000 0.0011 refjRattus norvegicus crystallin, lambda
1 (Cryl1), mRNA [NM_175757]
A_44_P311326 Cyp2b2 NM_001198676 1.17 0.0003 0.0300 refjRattus norvegicus cytochrome P450,
family 2, subfamily b, polypeptide 2
(Cyp2b2), mRNA [NM_001198676]
A_43_P11512 Spink3 M35299 1.17 0.0031 0.0876 gbjRat pancreatic secretory trypsin
inhibitor-like protein (PSTI) mRNA,
complete cds. [M35299]
A_42_P754888 Dlk1 NM_053744 1.15 0.0010 0.0545 refjRattus norvegicus delta-like 1
homolog (Drosophila) (Dlk1), mRNA
[NM_053744]
A_44_P349781 Nfe2 NM_001012224 1.15 0.0022 0.0777 refjRattus norvegicus nuclear factor,
erythroid derived 2 (Nfe2), mRNA
[NM_001012224]
A_44_P1037342 Cyp3a9 NM_147206 1.14 0.0003 0.0287 refjRattus norvegicus cytochrome P450,
family 3, subfamily a, polypeptide 9
(Cyp3a9), mRNA [NM_147206]
A_44_P174374 Ephx1 NM_012844 1.12 0.0001 0.0166 refjRattus norvegicus epoxide hydrolase
1, microsomal (Ephx1), transcript
variant 2, mRNA [NM_012844]
A_44_P623578 TC600277 TC600277 1.04 0.0002 0.0274 Unknown
A_44_P370267 Ethe1 NM_001106234 1.04 0.0040 0.0945 refjRattus norvegicus ethylmalonic
encephalopathy 1 (Ethe1), nuclear gene
encoding mitochondrial protein, mRNA
[NM_001106234]
A_43_P11484 Mme NM_012608 1.03 0.0001 0.0201 refjRattus norvegicus membrane
metallo-endopeptidase (Mme), mRNA
[NM_012608]




A_42_P703647 Cda NM_001108688 0.98 0.0000 0.0011 refjRattus norvegicus cytidine
deaminase (Cda), mRNA
[NM_001108688]
A_42_P573296 Hdc NM_017016 0.97 0.0000 0.0090 refjRattus norvegicus histidine
decarboxylase (Hdc), mRNA
[NM_017016]
A_43_P15534 Slco1a1 NM_017111 0.96 0.0000 0.0000 refjRattus norvegicus solute carrier
organic anion transporter family,
member 1a1 (Slco1a1), mRNA
[NM_017111]
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A_44_P210202 Polg NM_053528 0.96 0.0001 0.0149 refjRattus norvegicus polymerase (DNA
directed), gamma (Polg), mRNA
[NM_053528]
A_43_P11754 Akr7a3 NM_013215 0.95 0.0002 0.0275 refjRattus norvegicus aldo-keto
reductase family 7, member A3
(aﬂatoxin aldehyde reductase)
(Akr7a3), mRNA [NM_013215]
A_44_P128201 U25282 U25282 0.95 0.0006 0.0418 gbjRattus norvegicus brush border
myosin I (BBMI) mRNA, alternatively
spliced testis-speciﬁc variant, partial
cds. [U25282]




A_44_P210198 Polg NM_053528 0.90 0.0000 0.0121 refjRattus norvegicus polymerase (DNA
directed), gamma (Polg), mRNA
[NM_053528]
A_43_P13967 Gsta2 NM_017013 0.89 0.0010 0.0559 refjRattus norvegicus glutathione S-
transferase A2 (Gsta2), mRNA
[NM_017013]
A_44_P371125 Sult1b1 NM_022513 0.89 0.0000 0.0114 refjRattus norvegicus sulfotransferase
family, cytosolic, 1B, member 1
(Sult1b1), mRNA [NM_022513]
A_43_P17939 TC644990 TC644990 0.87 0.0000 0.0001 tcjBC007785 SNX8 protein {Homo
sapiens} (exp=-1; wgp=0; cg=0), partial
(33%) [TC644990]
A_44_P604927 FQ217318 FQ217318 0.86 0.0000 0.0005 gbjRattus norvegicus TL0ACA2YC11
mRNA sequence. [FQ217318]
A_42_P580844 Cdk1 NM_019296 0.84 0.0007 0.0468 refjRattus norvegicus cyclin-dependent
kinase 1 (Cdk1), mRNA [NM_019296]




A_44_P231243 Insig2 NM_178091 0.82 0.0000 0.0106 refjRattus norvegicus insulin induced
gene 2 (Insig2), mRNA [NM_178091]
A_43_P12233 Sult1b1 NM_022513 0.80 0.0001 0.0138 refjRattus norvegicus sulfotransferase
family, cytosolic, 1B, member 1
(Sult1b1), mRNA [NM_022513]
A_44_P544661 Cyp3a2 NM_153312 0.80 0.0007 0.0484 refjRattus norvegicus cytochrome P450,
family 3, subfamily a, polypeptide 2
(Cyp3a2), mRNA [NM_153312]
A_44_P864923 FQ214383 FQ214383 0.80 0.0001 0.0180 gbjRattus norvegicus TL0AAA41YP21
mRNA sequence. [FQ214383]
A_44_P219628 Ggt1 NM_053840 0.80 0.0002 0.0244 refjRattus norvegicus gamma-
glutamyltransferase 1 (Ggt1), mRNA
[NM_053840]
A_44_P808295 TC612707 TC612707 0.76 0.0010 0.0545 tcj2008147A protein RAKb. {Rattus
norvegicus} (exp=-1; wgp=-1; cg=-1),
partial (13%) [TC612707]
A_44_P115886 RGD1309534 NM_001014206 0.75 0.0005 0.0405 refjRattus norvegicus similar to RIKEN
cDNA 4931406C07 (RGD1309534),
mRNA [NM_001014206]
A_43_P11776 Gstm1 NM_017014 0.75 0.0018 0.0716 refjRattus norvegicus glutathione S-
transferase mu 1 (Gstm1), mRNA
[NM_017014]
A_44_P1009594 Cyp3a62 NM_001024232 0.75 0.0003 0.0298 refjRattus norvegicus cytochrome P450,
family 3, subfamily a, polypeptide 62
(Cyp3a62), mRNA [NM_001024232]
A_44_P1071390 AY156086 AY156086 0.74 0.0000 0.0032 gbjRattus norvegicus INSIG2a (Insig2)
mRNA, 50 untranslated region,
alternatively spliced. [AY156086]
A_43_P17743 Pir NM_001009474 0.74 0.0001 0.0138 refjRattus norvegicus pirin (iron-
binding nuclear protein) (Pir), mRNA
[NM_001009474]
A_44_P109455 Gstm2 NM_177426 0.73 0.0003 0.0304 refjRattus norvegicus glutathione S-
transferase mu 2 (Gstm2), mRNA
[NM_177426]
A_44_P638952 TC604219 TC604219 0.71 0.0023 0.0777 tcjQ6XJV6_MOUSE (Q6XJV6) CD200 cell
surface glycoprotein receptor isoform 2,
partial (15%) [TC604219]
A_44_P605947 Ces2h NM_001044258 0.70 0.0000 0.0008 refjRattus norvegicus carboxylesterase
2H (Ces2h), transcript variant 1, mRNA
[NM_001044258]
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A_43_P11481 Me1 NM_012600 0.69 0.0027 0.0815 refjRattus norvegicus malic enzyme 1,
NADP(+)-dependent, cytosolic (Me1),
mRNA [NM_012600]
A_43_P22556 Cidea NM_001170467 0.69 0.0028 0.0834 refjRattus norvegicus cell death-
inducing DFFA-like effector a (Cidea),
mRNA [NM_001170467]
A_44_P1056309 Snx8 NM_001105912 0.66 0.0000 0.0027 refjRattus norvegicus sorting nexin 8
(Snx8), mRNA [NM_001105912]
A_44_P287250 Oat NM_022521 0.64 0.0025 0.0792 refjRattus norvegicus ornithine
aminotransferase (Oat), nuclear gene
encoding mitochondrial protein, mRNA
[NM_022521]
A_44_P452797 RGD1309534 NM_001014206 0.64 0.0009 0.0538 refjRattus norvegicus similar to RIKEN
cDNA 4931406C07 (RGD1309534),
mRNA [NM_001014206]
A_44_P899264 Lhfpl2 NM_001106402 0.63 0.0009 0.0539 refjRattus norvegicus lipoma HMGIC
fusion partner-like 2 (Lhfpl2), mRNA
[NM_001106402]
A_43_P16697 TC584707 TC584707 0.63 0.0000 0.0014 tcjQ6PGC7_MOUSE (Q6PGC7) Solute
carrier family 35, member E3, partial
(45%) [TC584707]
A_44_P639283 TC627850 TC627850 0.63 0.0003 0.0298 Unknown
A_44_P1042952 Hrk NM_057130 0.62 0.0001 0.0198 refjRattus norvegicus harakiri, BCL2
interacting protein (contains only BH3
domain) (Hrk), mRNA [NM_057130]
A_43_P12029 Rgs5 NM_019341 0.62 0.0001 0.0151 refjRattus norvegicus regulator of G-
protein signaling 5 (Rgs5), mRNA
[NM_019341]
A_42_P572725 Abcc3 NM_080581 0.61 0.0032 0.0876 refjRattus norvegicus ATP-binding
cassette, subfamily C (CFTR/MRP),
member 3 (Abcc3), mRNA
[NM_080581]
A_44_P287842 Cyp2c22 NM_138512 0.61 0.0002 0.0235 refjRattus norvegicus cytochrome P450,
family 2, subfamily c, polypeptide 22
(Cyp2c22), mRNA [NM_138512]
A_44_P898999 A_44_P898999 A_44_P898999 0.61 0.0000 0.0093 Unknown
A_44_P212189 BF291149 BF291149 0.59 0.0000 0.0056 gbjEST455740 Rat Gene Index,
normalized rat, Rattus norvegicus cDNA
Rattus norvegicus cDNA clone RGIIJ36
30 sequence, mRNA sequence
[BF291149]
A_42_P585328 Xrcc1 NM_053435 0.59 0.0000 0.0056 refjRattus norvegicus X-ray repair
complementing defective repair in
Chinese hamster cells 1 (Xrcc1), mRNA
[NM_053435]
A_44_P129053 TC645262 TC645262 0.59 0.0025 0.0792 gbjAA848383 EST191143 Normalized
rat kidney, Bento Soares Rattus sp.
cDNA clone RKIAB83 50 end, mRNA
sequence [AA848383]
A_44_P114184 Ccdc80 NM_022543 0.58 0.0005 0.0388 refjRattus norvegicus coiled-coil
domain containing 80 (Ccdc80), mRNA
[NM_022543]
A_44_P273777 Masp1 NM_022257 0.58 0.0001 0.0160 refjRattus norvegicus mannan-binding
lectin serine peptidase 1 (Masp1),
mRNA [NM_022257]
A_44_P1042711 Kif20a NM_001108426 0.57 0.0009 0.0533 refjRattus norvegicus kinesin family
member 20A (Kif20a), mRNA
[NM_001108426]
A_42_P763522 Cyyr1 NM_001013980 0.57 0.0007 0.0463 refjRattus norvegicus cysteine/tyrosine-
rich 1 (Cyyr1), mRNA [NM_001013980]
A_44_P179787 Panx2 NM_199409 0.56 0.0011 0.0574 refjRattus norvegicus pannexin 2
(Panx2), mRNA [NM_199409]
A_44_P634946 Mdm2 NM_001108099 0.56 0.0000 0.0009 refjRattus norvegicus Mdm2 p53
binding protein homolog (mouse)
(Mdm2), mRNA [NM_001108099]
A_44_P141897 Abcb1b NM_012623 0.56 0.0000 0.0002 refjRattus norvegicus ATP-binding
cassette, subfamily B (MDR/TAP),
member 1B (Abcb1b), mRNA
[NM_012623]
A_44_P319238 Cpne4 NM_001109003 0.56 0.0002 0.0234 refjRattus norvegicus copine IV (Cpne4),
mRNA [NM_001109003]
A_44_P500880 App NM_019288 0.55 0.0000 0.0116 refjRattus norvegicus amyloid beta (A4)
precursor protein (App), mRNA
[NM_019288]
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A_44_P104483 Ccdc64 NM_001191667 0.55 0.0001 0.0176 refjRattus norvegicus coiled-coil
domain containing 64 (Ccdc64), mRNA
[NM_001191667]
A_44_P140092 Myh14 NM_001100690 0.53 0.0004 0.0354 refjRattus norvegicus myosin, heavy
chain 14, non-muscle (Myh14), mRNA
[NM_001100690]
A_42_P460340 Mal2 NM_198786 0.53 0.0003 0.0317 refjRattus norvegicus mal, T-cell
differentiation protein 2 (Mal2), mRNA
[NM_198786]
A_44_P401165 Stmn1 NM_017166 0.53 0.0011 0.0580 refjRattus norvegicus stathmin 1
(Stmn1), mRNA [NM_017166]
A_42_P735417 Fcgr2b NM_175756 0.53 0.0032 0.0884 refjRattus norvegicus Fc fragment of
IgG, low afﬁnity IIb, receptor (CD32)
(Fcgr2b), mRNA [NM_175756]
A_43_P11891 Adh4 NM_017270 0.52 0.0044 0.0998 refjRattus norvegicus alcohol
dehydrogenase 4 (class II), pi
polypeptide (Adh4), mRNA
[NM_017270]
A_42_P654578 Cyp2a1 NM_012692 0.52 0.0018 0.0712 refjRattus norvegicus cytochrome P450,
family 2, subfamily a, polypeptide 1
(Cyp2a1), mRNA [NM_012692]
A_44_P674018 Acer2 NM_001107943 0.51 0.0016 0.0697 refjRattus norvegicus alkaline
ceramidase 2 (Acer2), mRNA
[NM_001107943]
A_44_P1018147 Isoc1 NM_001014242 0.51 0.0022 0.0772 refjRattus norvegicus isochorismatase
domain containing 1 (Isoc1), mRNA
[NM_001014242]
A_42_P491707 FQ226403 FQ226403 0.51 0.0044 0.0992 gbjRattus norvegicus TL0AEA2YE23
mRNA sequence. [FQ226403]
A_44_P809374 Clcf1 NM_207615 0.51 0.0002 0.0257 refjRattus norvegicus cardiotrophin-
like cytokine factor 1 (Clcf1), mRNA
[NM_207615]
A_44_P325666 Cyp2d2 NM_012730 0.51 0.0002 0.0243 refjRattus norvegicus cytochrome P450,
family 2, subfamily d, polypeptide 2
(Cyp2d2), mRNA [NM_012730]
A_44_P715425 TC588735 TC588735 0.51 0.0000 0.0009 Unknown
A_44_P168405 Fcgr2a NM_053843 0.51 0.0034 0.0896 refjRattus norvegicus Fc fragment of
IgG, low afﬁnity IIa, receptor (CD32)
(Fcgr2a), mRNA [NM_053843]
A_44_P930534 Gas2 NM_001127504 0.50 0.0038 0.0929 refjRattus norvegicus growth arrest-
speciﬁc 2 (Gas2), mRNA
[NM_001127504]




A_44_P993370 Fermt2 NM_001011915 0.49 0.0001 0.0184 refjRattus norvegicus fermitin family
member 2 (Fermt2), mRNA
[NM_001011915]
A_44_P365358 Tusc3 NM_001004212 0.49 0.0001 0.0148 refjRattus norvegicus tumor suppressor
candidate 3 (Tusc3), mRNA
[NM_001004212]
A_44_P700498 Angptl3 NM_001025065 0.48 0.0002 0.0224 refjRattus norvegicus angiopoietin-like
3 (Angptl3), mRNA [NM_001025065]
A_44_P517880 Fgf1 NM_012846 0.48 0.0001 0.0135 refjRattus norvegicus ﬁbroblast growth
factor 1 (Fgf1), mRNA [NM_012846]
A_44_P743168 AI412180 AI412180 0.48 0.0001 0.0160 gbjAI412180 EST240474 Normalized
rat kidney, Bento Soares Rattus sp.
cDNA clone RKIEP46 30 end, mRNA
sequence [AI412180]
A_43_P16515 TC579683 TC579683 0.48 0.0004 0.0326 tcjQ6K0P5_RAT (Q6K0P5) PRP2,
complete [TC579683]
A_44_P135224 Plk3 NM_022187 0.48 0.0009 0.0538 refjRattus norvegicus polo-like kinase 3
(Plk3), mRNA [NM_022187]
A_44_P405443 Manba NM_001031655 0.48 0.0001 0.0160 refjRattus norvegicus mannosidase,
beta A, lysosomal (Manba), mRNA
[NM_001031655]
A_44_P992535 Gpr116 NM_139110 0.48 0.0003 0.0298 refjRattus norvegicus G protein-coupled
receptor 116 (Gpr116), mRNA
[NM_139110]
A_44_P519251 Cd14 NM_021744 0.48 0.0032 0.0884 refjRattus norvegicus CD14 molecule
(Cd14), mRNA [NM_021744]
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A_44_P883793 TC611717 TC611717 0.48 0.0009 0.0536 Unknown
A_44_P226832 Rasgrf1 NM_001170531 0.47 0.0027 0.0827 refjRattus norvegicus RAS protein-
speciﬁc guanine nucleotide-releasing
factor 1 (Rasgrf1), transcript variant 1,
mRNA [NM_001170531]
A_44_P805242 TC588735 TC588735 0.47 0.0000 0.0106 gbjAW917651 EST348955 Rat gene
index, normalized rat, norvegicus,
Bento Soares Rattus norvegicus cDNA
clone RGIEG45 50 end, mRNA sequence
[AW917651]
A_44_P509500 Akap2 NM_001011974 0.47 0.0002 0.0235 refjRattus norvegicus A kinase (PRKA)
anchor protein 2 (Akap2), mRNA
[NM_001011974]
A_44_P1043208 Snx14 NM_001108174 0.46 0.0005 0.0385 refjRattus norvegicus sorting nexin 14
(Snx14), mRNA [NM_001108174]
A_43_P17763 Scrn3 ENSRNOT00000025255 0.46 0.0006 0.0418 ensjsecernin-3 [Source:RefSeq
peptide;Acc:NP_001013180]
[ENSRNOT00000025255]
A_44_P228874 Gclc NM_012815 0.46 0.0005 0.0393 refjRattus norvegicus glutamate-
cysteine ligase, catalytic subunit (Gclc),
mRNA [NM_012815]
A_44_P356027 Sc5dl NM_053642 0.46 0.0034 0.0896 refjRattus norvegicus sterol-C5-
desaturase (ERG3 delta-5-desaturase
homolog, S. cerevisiae)-like (Sc5dl),
mRNA [NM_053642]
A_44_P296924 Rdh10 NM_181478 0.45 0.0000 0.0094 refjRattus norvegicus retinol
dehydrogenase 10 (all-trans) (Rdh10),
mRNA [NM_181478]
A_43_P14566 Aatf NM_053720 0.45 0.0015 0.0680 refjRattus norvegicus apoptosis
antagonizing transcription factor (Aatf),
mRNA [NM_053720]
A_44_P398167 Prdx1 NM_057114 0.45 0.0001 0.0133 refjRattus norvegicus peroxiredoxin 1
(Prdx1), mRNA [NM_057114]
A_44_P604787 TC586784 TC586784 0.45 0.0010 0.0547 gbjAW917268 EST348572 Rat gene
index, normalized rat, norvegicus,
Bento Soares Rattus norvegicus cDNA
clone RGIEB53 50 end, mRNA sequence
[AW917268]
A_44_P575340 Hprt1 NM_012583 0.45 0.0001 0.0160 refjRattus norvegicus hypoxanthine
phosphoribosyltransferase 1 (Hprt1),
mRNA [NM_012583]
A_43_P11580 Abcc2 NM_012833 0.45 0.0010 0.0546 refjRattus norvegicus ATP-binding
cassette, subfamily C (CFTR/MRP),
member 2 (Abcc2), mRNA
[NM_012833]
A_44_P319080 Car8 NM_001009662 0.45 0.0005 0.0393 refjRattus norvegicus carbonic
anhydrase 8 (Car8), mRNA
[NM_001009662]
A_44_P728623 TC634460 TC634460 0.45 0.0007 0.0463 tcjQ6NS70_MOUSE (Q6NS70)
LOC547091 protein, partial (46%)
[TC634460]
A_44_P249990 Mal2 NM_198786 0.44 0.0006 0.0421 refjRattus norvegicus mal, T-cell
differentiation protein 2 (Mal2), mRNA
[NM_198786]
A_43_P11861 Dio3 NM_017210 0.44 0.0028 0.0831 refjRattus norvegicus deiodinase,
iodothyronine, type III (Dio3), mRNA
[NM_017210]
A_42_P631122 Cd302 NM_001013916 0.44 0.0005 0.0408 refjRattus norvegicus CD302 molecule
(Cd302), mRNA [NM_001013916]
A_44_P543096 Serpina10 NM_133617 0.44 0.0026 0.0814 refjRattus norvegicus serine (or
cysteine) peptidase inhibitor, clade A
(alpha-1 antiproteinase, antitrypsin),
member 10 (Serpina10), mRNA
[NM_133617]
A_44_P536832 Dennd2a XM_231654 0.44 0.0003 0.0298 gbjRattus norvegicus similar to RIKEN
cDNA B930096L08 (LOC312257), mRNA
[XM_231654]
A_43_P21402 CB546753 CB546753 0.44 0.0001 0.0180 gbjCB546753 AMGNNUC:NRPC1-
00004-D7-A nrpc1 (10212) Rattus
norvegicus cDNA clone nrpc1-00004-d7
50 , mRNA sequence [CB546753]
A_44_P714816 TC612754 TC612754 0.43 0.0008 0.0507 Unknown
A_42_P455982 Pgm2 NM_001106007 0.43 0.0013 0.0631 refjRattus norvegicus
phosphoglucomutase 2 (Pgm2), mRNA
[NM_001106007]
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A_43_P13409 Zdhhc2 NM_145096 0.43 0.0033 0.0889 refjRattus norvegicus zinc ﬁnger,
DHHC-type containing 2 (Zdhhc2),
mRNA [NM_145096]
A_44_P365155 Hprt1 NM_012583 0.43 0.0003 0.0290 refjRattus norvegicus hypoxanthine
phosphoribosyltransferase 1 (Hprt1),
mRNA [NM_012583]
A_44_P512828 Nup210 NM_053322 0.42 0.0010 0.0546 refjRattus norvegicus nucleoporin 210
(Nup210), mRNA [NM_053322]
A_44_P342334 A_44_P342334 A_44_P342334 0.42 0.0003 0.0319 Unknown
A_42_P623688 Gatm NM_031031 0.42 0.0012 0.0622 refjRattus norvegicus glycine
amidinotransferase (L-arginine:glycine
amidinotransferase) (Gatm), nuclear
gene encoding mitochondrial protein,
mRNA [NM_031031]
A_44_P340434 Ttc38 NM_001130499 0.42 0.0002 0.0275 refjRattus norvegicus tetratricopeptide
repeat domain 38 (Ttc38), mRNA
[NM_001130499]
A_44_P293948 Ghitm NM_001005908 0.41 0.0025 0.0800 refjRattus norvegicus growth hormone
inducible transmembrane protein
(Ghitm), mRNA [NM_001005908]
A_44_P1057690 Dnase1l3 NM_053907 0.41 0.0006 0.0424 refjRattus norvegicus
deoxyribonuclease 1-like 3 (Dnase1l3),
mRNA [NM_053907]
A_42_P550172 Hip1r NM_001134763 0.41 0.0038 0.0931 refjRattus norvegicus huntingtin
interacting protein 1 related (Hip1r),
transcript variant 1, mRNA
[NM_001134763]
A_44_P499327 Ggct NM_001108629 0.41 0.0000 0.0027 refjRattus norvegicus gamma-glutamyl
cyclotransferase (Ggct), mRNA
[NM_001108629]
A_44_P534089 Ccnb1 NM_171991 0.41 0.0033 0.0889 refjRattus norvegicus cyclin B1 (Ccnb1),
mRNA [NM_171991]
A_44_P227286 XM_234810 XM_234810 0.41 0.0008 0.0520 gbjRattus norvegicus similar to
glutathione S-transferase 8 (GST 8-8)
(CHAIN 8) (GST CLASS-ALPHA)
(LOC314570), mRNA [XM_234810]
A_42_P518462 Hmgn3 NM_001007020 0.41 0.0042 0.0966 refjRattus norvegicus high mobility
group nucleosomal binding domain 3
(Hmgn3), transcript variant 2, mRNA
[NM_001007020]
A_44_P236068 Ugt2b36 NM_001004271 0.41 0.0002 0.0252 refjRattus norvegicus UDP
glucuronosyltransferase 2 family,
polypeptide B36 (Ugt2b36), mRNA
[NM_001004271]
A_43_P14688 FQ211316 FQ211316 0.41 0.0016 0.0685 gbjRattus norvegicus TL0ABA13YA24
mRNA sequence. [FQ211316]
A_44_P1014862 Ubxn8 NM_001106086 0.41 0.0001 0.0160 refjRattus norvegicus UBX domain
protein 8 (Ubxn8), mRNA
[NM_001106086]
A_44_P1019407 Rnf103 NM_053438 0.41 0.0004 0.0351 refjRattus norvegicus ring ﬁnger protein
103 (Rnf103), mRNA [NM_053438]
A_44_P591548 Papd7 NM_001107333 0.41 0.0001 0.0200 refjRattus norvegicus PAP associated
domain containing 7 (Papd7), mRNA
[NM_001107333]
A_44_P1022458 Tubb6 NM_001025675 0.40 0.0034 0.0896 refjRattus norvegicus tubulin, beta 6
(Tubb6), mRNA [NM_001025675]
A_44_P493606 Camk2n1 NM_173337 0.40 0.0020 0.0748 refjRattus norvegicus calcium/
calmodulin-dependent protein kinase II
inhibitor 1 (Camk2n1), mRNA
[NM_173337]
A_44_P274526 RGD1311378 NM_001106547 0.40 0.0006 0.0421 refjRattus norvegicus similar to RIKEN
cDNA 2010011I20 (RGD1311378),
mRNA [NM_001106547]
A_44_P233963 Mras NM_012981 0.40 0.0020 0.0752 refjRattus norvegicus muscle RAS
oncogene homolog (Mras), mRNA
[NM_012981]
A_44_P851230 TC587902 TC587902 0.40 0.0021 0.0765 gbjBF558478 UI-R-C1-la-e-02-0-UI.r1
UI-R-C1 Rattus norvegicus cDNA clone
UI-R-C1-la-e-02-0-UI 50 , mRNA
sequence [BF558478]
A_42_P519868 Gsr NM_053906 0.40 0.0005 0.0385 refjRattus norvegicus glutathione
reductase (Gsr), mRNA [NM_053906]
A_42_P505393 Serpinb6a NM_199085 0.40 0.0016 0.0697 refjRattus norvegicus serine (or
cysteine) peptidase inhibitor, clade B,
member 6a (Serpinb6a), mRNA
[NM_199085]
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A_44_P215253 N4bp2l1 NM_001035222 0.39 0.0017 0.0705 refjRattus norvegicus NEDD4 binding
protein 2-like 1 (N4bp2l1), mRNA
[NM_001035222]
A_44_P837036 A_44_P837036 A_44_P837036 0.39 0.0014 0.0657 Unknown
A_44_P293944 Ghitm NM_001005908 0.39 0.0014 0.0648 refjRattus norvegicus growth hormone
inducible transmembrane protein
(Ghitm), mRNA [NM_001005908]
A_43_P19850 TC622988 TC622988 0.39 0.0001 0.0201 tcjQ6NS70_MOUSE (Q6NS70)
LOC547091 protein, partial (10%)
[TC622988]
A_44_P423662 Sh3bp5 NM_054011 0.39 0.0021 0.0765 refjRattus norvegicus SH3-domain
binding protein 5 (BTK-associated)
(Sh3bp5), mRNA [NM_054011]




A_44_P113933 Tyms NM_019179 0.39 0.0006 0.0427 refjRattus norvegicus thymidylate
synthetase (Tyms), mRNA
[NM_019179]




A_42_P531078 Gsta4 NM_001106840 0.39 0.0002 0.0257 refjRattus norvegicus glutathione S-
transferase alpha 4 (Gsta4), mRNA
[NM_001106840]
A_44_P370015 Pgrmc1 NM_021766 0.39 0.0000 0.0065 refjRattus norvegicus progesterone
receptor membrane component 1
(Pgrmc1), mRNA [NM_021766]
A_44_P1043302 Crb3 NM_001025661 0.39 0.0017 0.0697 refjRattus norvegicus crumbs homolog
3 (Drosophila) (Crb3), mRNA
[NM_001025661]
A_44_P1001963 TC595761 TC595761 0.39 0.0001 0.0160 tcjQ7R8P9_PLAYO (Q7R8P9)
Homeobox-containing protein
(Fragment), partial (5%) [TC595761]
A_44_P400211 Sgpl1 NM_173116 0.39 0.0023 0.0777 refjRattus norvegicus sphingosine-1-
phosphate lyase 1 (Sgpl1), mRNA
[NM_173116]
A_43_P20296 Ppp2r3c NM_001014196 0.39 0.0023 0.0777 refjRattus norvegicus protein
phosphatase 2, regulatory subunit B00 ,
gamma (Ppp2r3c), mRNA
[NM_001014196]




A_44_P461187 St3gal4 NM_203337 0.38 0.0001 0.0201 refjRattus norvegicus ST3 beta-
galactoside alpha-2,3-sialyltransferase
4 (St3gal4), mRNA [NM_203337]
A_44_P698199 A_44_P698199 A_44_P698199 0.38 0.0016 0.0684 Unknown
A_44_P389389 Ttll9 NM_001014051 0.38 0.0026 0.0813 refjRattus norvegicus tubulin tyrosine
ligase-like family, member 9 (Ttll9),
mRNA [NM_001014051]
A_44_P501204 Nup54 NM_017361 0.38 0.0021 0.0766 refjRattus norvegicus nucleoporin 54
(Nup54), mRNA [NM_017361]
A_44_P374586 Cyb5a NM_022245 0.38 0.0000 0.0033 refjRattus norvegicus cytochrome b5
type A (microsomal) (Cyb5a), mRNA
[NM_022245]
A_44_P948250 Il13ra1 NM_145789 0.38 0.0008 0.0508 refjRattus norvegicus interleukin 13
receptor, alpha 1 (Il13ra1), mRNA
[NM_145789]
A_44_P869774 Clec1b NM_001191978 0.38 0.0010 0.0553 refjRattus norvegicus C-type lectin
domain family 1, member B (Clec1b),
mRNA [NM_001191978]
A_44_P298064 Gas2 NM_001127504 0.38 0.0004 0.0326 refjRattus norvegicus growth arrest-
speciﬁc 2 (Gas2), mRNA
[NM_001127504]




A_44_P281482 Chchd6 NM_001106608 0.38 0.0013 0.0637 refjRattus norvegicus coiled-coil-helix-
coiled-coil-helix domain containing 6
(Chchd6), mRNA [NM_001106608]
A_44_P466614 Lactb2 NM_001024247 0.37 0.0020 0.0752 refjRattus norvegicus lactamase, beta 2
(Lactb2), mRNA [NM_001024247]
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A_44_P369493 Ccdc17 NM_001014067 0.37 0.0034 0.0896 refjRattus norvegicus coiled-coil
domain containing 17 (Ccdc17), mRNA
[NM_001014067]
A_44_P133650 Trim37 NM_001108288 0.37 0.0009 0.0545 refjRattus norvegicus tripartite motif-
containing 37 (Trim37), mRNA
[NM_001108288]




A_43_P11848 Bmp2 NM_017178 0.36 0.0001 0.0180 refjRattus norvegicus bone
morphogenetic protein 2 (Bmp2),
mRNA [NM_017178]




A_44_P177793 A_44_P177793 A_44_P177793 0.36 0.0009 0.0538 Unknown
A_44_P1034068 LOC100364126 XM_002726281 0.36 0.0005 0.0385 refjPREDICTED: Rattus norvegicus
sorting nexin 21-like (LOC100364126),
partial mRNA [XM_002726281]




A_43_P12460 Lrrn3 NM_030856 0.36 0.0004 0.0375 refjRattus norvegicus leucine rich
repeat neuronal 3 (Lrrn3), mRNA
[NM_030856]
A_44_P579594 Dse NM_001108933 0.36 0.0031 0.0876 refjRattus norvegicus dermatan sulfate
epimerase (Dse), mRNA
[NM_001108933]
A_44_P399459 Col4a3bp NM_001108935 0.36 0.0019 0.0729 refjRattus norvegicus collagen, type IV,
alpha 3 (Goodpasture antigen) binding
protein (Col4a3bp), mRNA
[NM_001108935]
A_44_P526425 Selt NM_001014253 0.36 0.0016 0.0692 refjRattus norvegicus selenoprotein T
(Selt), mRNA [NM_001014253]




A_43_P12007 Slc3a2 NM_019283 0.35 0.0022 0.0768 refjRattus norvegicus solute carrier
family 3 (activators of dibasic and
neutral amino acid transport), member
2 (Slc3a2), mRNA [NM_019283]
A_44_P553751 Avpi1 NM_134373 0.35 0.0030 0.0859 refjRattus norvegicus arginine
vasopressin-induced 1 (Avpi1), mRNA
[NM_134373]
A_44_P382363 Amn1 NM_001008333 0.35 0.0019 0.0735 refjRattus norvegicus antagonist of
mitotic exit network 1 homolog (S.
cerevisiae) (Amn1), mRNA
[NM_001008333]
A_44_P745027 A_44_P745027 A_44_P745027 0.35 0.0014 0.0660 Unknown
A_44_P531727 LOC367195 NM_001047920 0.35 0.0031 0.0876 refjRattus norvegicus similar to 60S
RIBOSOMAL PROTEIN L7 (LOC367195),
mRNA [NM_001047920]
A_42_P816767 Nt5c3 NM_001107862 0.35 0.0015 0.0673 refjRattus norvegicus 50-nucleotidase,
cytosolic III (Nt5c3), mRNA
[NM_001107862]




A_44_P369389 Capn5 FQ223532 0.35 0.0002 0.0229 gbjRattus norvegicus TL0ADA10YB20
mRNA sequence. [FQ223532]




A_44_P981679 Fam118a NM_001173336 0.34 0.0012 0.0611 refjRattus norvegicus family with
sequence similarity 118, member A
(Fam118a), mRNA [NM_001173336]
A_44_P775631 RGD1564854 NM_001109341 0.34 0.0007 0.0474 refjRattus norvegicus similar to divalent
cation tolerant protein CUTA
(RGD1564854), mRNA
[NM_001109341]
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A_44_P274762 Cpped1 NM_001013963 0.34 0.0013 0.0631 refjRattus norvegicus calcineurin-like
phosphoesterase domain containing 1
(Cpped1), mRNA [NM_001013963]
A_44_P461314 Gucy1b2 NM_012770 0.34 0.0006 0.0418 refjRattus norvegicus guanylate cyclase
1, soluble, beta 2 (Gucy1b2), mRNA
[NM_012770]
A_44_P777928 Ttc38 FQ210197 0.34 0.0005 0.0418 gbjRattus norvegicus TL0ABA32YM14
mRNA sequence. [FQ210197]
A_44_P975601 Phf11l NM_001014235 0.34 0.0026 0.0814 refjRattus norvegicus PHD ﬁnger
protein 11-like (Phf11l), mRNA
[NM_001014235]
A_44_P424335 Ces2g NM_001106175 0.34 0.0015 0.0665 refjRattus norvegicus carboxylesterase
2G (Ces2g), mRNA [NM_001106175]
A_44_P136679 Isoc1 NM_001014242 0.34 0.0026 0.0814 refjRattus norvegicus isochorismatase
domain containing 1 (Isoc1), mRNA
[NM_001014242]
A_44_P432937 TC592288 TC592288 0.34 0.0004 0.0345 tcjQ5XI04_RAT (Q5XI04) Stomatin
(Predicted), complete [TC592288]
A_44_P989111 TC590171 TC590171 0.34 0.0006 0.0453 tcjQ91842_XENLA (Q91842) Xenopus
laevis U2 snRNA gene, partial (6%)
[TC590171]
A_44_P541378 Isoc1 NM_001014242 0.33 0.0013 0.0640 refjRattus norvegicus isochorismatase
domain containing 1 (Isoc1), mRNA
[NM_001014242]
A_44_P965553 CA503908 CA503908 0.33 0.0016 0.0684 gbjUI-R-FS1-cqe-a-24-0-UI.s1 UI-R-FS1
Rattus norvegicus cDNA clone UI-R-
FS1-cqe-a-24-0-UI 30 , mRNA sequence
[CA503908]
A_43_P11622 Cd59 NM_012925 0.32 0.0012 0.0599 refjRattus norvegicus CD59 molecule,
complement regulatory protein (Cd59),
mRNA [NM_012925]
A_44_P159430 Calml4 NM_001127575 0.32 0.0002 0.0266 refjRattus norvegicus calmodulin-like 4
(Calml4), mRNA [NM_001127575]
A_44_P184865 Ptp4a1 L27843 0.32 0.0019 0.0735 gbjRattus norvegicus tyrosine
phosphatase (PRL-1) mRNA, complete
cds. [L27843]
A_44_P299282 Shank2 NM_133441 0.32 0.0015 0.0665 refjRattus norvegicus SH3 and multiple
ankyrin repeat domains 2 (Shank2),
transcript variant 4, mRNA
[NM_133441]
A_44_P513385 Dab2 NM_024159 0.32 0.0017 0.0707 refjRattus norvegicus disabled homolog
2 (Drosophila) (Dab2), mRNA
[NM_024159]
A_44_P420225 RGD1563982 NM_001110491 0.32 0.0039 0.0932 refjRattus norvegicus similar to F-box
only protein 27 (RGD1563982), mRNA
[NM_001110491]
A_44_P603871 TC587235 TC587235 0.32 0.0019 0.0727 tcjQ5C7U4_SCHJA (Q5C7U4)
SJCHGC08389 protein (Fragment),
partial (9%) [TC587235]
A_44_P715164 CB557922 CB557922 0.32 0.0008 0.0497 gbjAMGNNUC:NRHY5-00137-F10-A W
Rat hypothalamus (10471) Rattus
norvegicus cDNA clone nrhy5-00137-
f10 50 , mRNA sequence [CB557922]
A_44_P410000 Stx18 NM_001012151 0.32 0.0019 0.0729 refjRattus norvegicus syntaxin 18
(Stx18), mRNA [NM_001012151]




A_44_P160550 Capn2 NM_017116 0.32 0.0026 0.0813 refjRattus norvegicus calpain 2 (Capn2),
mRNA [NM_017116]
A_44_P190229 Fam58b NM_001025412 0.32 0.0014 0.0650 refjRattus norvegicus family with
sequence similarity 58, member B
(Fam58b), mRNA [NM_001025412]
A_44_P458319 TC590099 TC590099 0.31 0.0025 0.0795 gbjAW918893 EST350197 Rat gene
index, normalized rat, norvegicus,
Bento Soares Rattus norvegicus cDNA
clone RGIFA03 50 end, mRNA sequence
[AW918893]
A_44_P196824 Serpinb9 NM_001007732 0.31 0.0024 0.0789 refjRattus norvegicus serpin peptidase
inhibitor, clade B (ovalbumin), member
9 (Serpinb9), mRNA [NM_001007732]
A_44_P837602 TC645764 TC645764 0.31 0.0026 0.0804 tcjAF284830 carboxypeptidase D
isoform CPD-N {Rattus norvegicus}
(exp=-1; wgp=0; cg=0), complete
[TC581295]
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A_44_P853102 Dusp16 NM_001106624 0.31 0.0011 0.0580 gbjRattus norvegicus dual speciﬁcity
phosphatase 16 (Dusp16), mRNA
[NM_001106624]
A_44_P792470 RGD1563482 FQ211547 0.31 0.0038 0.0931 gbjRattus norvegicus TL0AAA88YM11
mRNA sequence. [FQ211547]
A_44_P269925 Acer2 NM_001107943 0.31 0.0031 0.0876 refjRattus norvegicus alkaline
ceramidase 2 (Acer2), mRNA
[NM_001107943]
A_44_P802937 FQ213704 FQ213704 0.31 0.0003 0.0295 gbjRattus norvegicus TL0AAA46YD19
mRNA sequence. [FQ213704]
A_44_P620208 FQ221790 FQ221790 0.31 0.0035 0.0896 gbjRattus norvegicus TL0ADA31YM21
mRNA sequence. [FQ221790]
A_44_P298730 TC581937 TC581937 0.31 0.0012 0.0599 tcjQ99LR9_MOUSE (Q99LR9) Riok3
protein (Fragment), partial (13%)
[TC581937]




A_42_P658815 Atp6v1e1 NM_198745 0.31 0.0013 0.0623 refjRattus norvegicus ATPase, H+
transporting, lysosomal V1 subunit E1
(Atp6v1e1), mRNA [NM_198745]
A_44_P270658 TC598704 TC598704 0.31 0.0004 0.0376 tcjQ6A808_PROAC (Q6A808) Peptide
chain release factor 2, partial (6%)
[TC598704]
A_44_P201385 Psmc6 NM_001100509 0.30 0.0035 0.0900 refjRattus norvegicus proteasome
(prosome, macropain) 26S subunit,
ATPase, 6 (Psmc6), mRNA
[NM_001100509]
A_44_P265911 Cnr2 NM_001164143 0.30 0.0008 0.0520 refjRattus norvegicus cannabinoid
receptor 2 (macrophage) (Cnr2),
transcript variant 1, mRNA
[NM_001164143]
A_43_P20587 Gypc NM_001013233 0.30 0.0011 0.0571 refjRattus norvegicus glycophorin C
(Gerbich blood group) (Gypc), mRNA
[NM_001013233]
A_42_P478706 LOC361990 NM_001014175 0.30 0.0021 0.0763 refjRattus norvegicus similar to
DKFZP547E1010 protein (LOC361990),
mRNA [NM_001014175]
A_44_P398587 Usp9x NM_001135893 0.30 0.0018 0.0713 refjRattus norvegicus ubiquitin speciﬁc
peptidase 9, X-linked (Usp9x),
transcript variant 1, mRNA
[NM_001135893]
A_42_P768355 Hrk NM_057130 0.30 0.0023 0.0777 refjRattus norvegicus harakiri, BCL2
interacting protein (contains only BH3
domain) (Hrk), mRNA [NM_057130]
A_44_P378514 TC637536 TC637536 0.30 0.0028 0.0829 tcjQ1ZZX1_MUSPR (Q1ZZX1) DELLA
protein (Fragment), partial (7%)
[TC637536]
A_42_P668972 Acp1 NM_021262 0.30 0.0003 0.0275 refjRattus norvegicus acid phosphatase
1, soluble (Acp1), transcript variant 1,
mRNA [NM_021262]
A_42_P477732 Slc10a1 NM_017047 0.30 0.0022 0.0777 refjRattus norvegicus solute carrier
family 10 (sodium/bile acid
cotransporter family), member 1
(Slc10a1), mRNA [NM_017047]
A_44_P125145 CF109884 CF109884 0.30 0.0008 0.0520 gbjShultzomica03135 Rat lung airway
and parenchyma cDNA libraries Rattus
norvegicus cDNA clone Contig2758 50 ,
mRNA sequence [CF109884]
A_42_P743301 Psma1 NM_017278 0.30 0.0018 0.0712 refjRattus norvegicus proteasome
(prosome, macropain) subunit, alpha
type 1 (Psma1), mRNA [NM_017278]
A_44_P105310 Elovl2 NM_001109118 0.30 0.0030 0.0854 refjRattus norvegicus elongation of very
long chain fatty acids (FEN1/Elo2, SUR4/
Elo3, yeast)-like 2 (Elovl2), mRNA
[NM_001109118]
A_44_P177333 TC633253 TC633253 0.29 0.0010 0.0545 tcjQ8R1U0_MOUSE (Q8R1U0) Cﬂar
protein, partial (82%) [TC632248]
A_44_P491831 Gsta5 NM_001009920 0.29 0.0017 0.0711 refjRattus norvegicus glutathione S-
transferase Yc2 subunit (Gsta5),
transcript variant 1, mRNA
[NM_001009920]
A_44_P284642 Ccdc104 NM_001024866 0.29 0.0031 0.0869 refjRattus norvegicus coiled-coil
domain containing 104 (Ccdc104),
mRNA [NM_001024866]
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A_44_P168112 Skp1 NM_001007608 0.29 0.0014 0.0664 refjRattus norvegicus S-phase kinase-
associated protein 1 (Skp1), mRNA
[NM_001007608]
A_44_P226601 F8 NM_183331 0.29 0.0018 0.0712 refjRattus norvegicus coagulation factor
VIII, procoagulant component (F8),
mRNA [NM_183331]
A_44_P929247 Cyp4f17 NM_001191986 0.29 0.0013 0.0640 refjRattus norvegicus cytochrome P450,
family 4, subfamily f, polypeptide 17
(Cyp4f17), mRNA [NM_001191986]
A_44_P741723 Il13ra1 NM_145789 0.29 0.0013 0.0640 refjRattus norvegicus interleukin 13
receptor, alpha 1 (Il13ra1), mRNA
[NM_145789]
A_44_P325744 Nap1l1 NM_053561 0.29 0.0037 0.0927 refjRattus norvegicus nucleosome
assembly protein 1-like 1 (Nap1l1),
mRNA [NM_053561]
A_43_P19545 Meis3 NM_001108472 0.29 0.0032 0.0884 refjRattus norvegicus Meis homeobox 3
(Meis3), mRNA [NM_001108472]
A_44_P793558 TC599526 TC599526 0.29 0.0000 0.0114 Unknown
A_44_P103020 Dbndd2 NM_001047111 0.29 0.0002 0.0275 refjRattus norvegicus dysbindin
(dystrobrevin binding protein 1)
domain containing 2 (Dbndd2), mRNA
[NM_001047111]






A_44_P562251 BF545174 BF545174 0.29 0.0002 0.0239 gbjUI-R-C2p-rx-c-04-0-UI.r1 UI-R-C2p
Rattus norvegicus cDNA clone UI-R-
C2p-rx-c-04-0-UI 50 , mRNA sequence
[BF545174]
A_43_P11552 Ptpra NM_012763 0.29 0.0009 0.0541 refjRattus norvegicus protein tyrosine
phosphatase, receptor type, A (Ptpra),
mRNA [NM_012763]
A_42_P462987 Vangl1 NM_001109584 0.29 0.0043 0.0984 refjRattus norvegicus vang-like 1 (van
gogh, Drosophila) (Vangl1), mRNA
[NM_001109584]
A_42_P637618 Fopnl NM_001108261 0.29 0.0022 0.0777 refjRattus norvegicus FGFR1OP N-
terminal like (Fopnl), mRNA
[NM_001108261]
A_44_P1031034 Clip1 NM_031745 0.28 0.0005 0.0416 refjRattus norvegicus CAP-GLY domain
containing linker protein 1 (Clip1),
mRNA [NM_031745]
A_42_P541784 RGD1566099 NM_001108347 0.28 0.0015 0.0673 refjRattus norvegicus similar to novel
protein (RGD1566099), mRNA
[NM_001108347]
A_44_P260268 Tinf2 NM_001006962 0.28 0.0044 0.0998 refjRattus norvegicus TERF1 (TRF1)-
interacting nuclear factor 2 (Tinf2),
mRNA [NM_001006962]
A_44_P713299 LOC684862 XM_001072231 0.28 0.0039 0.0935 refjPREDICTED: Rattus norvegicus
hypothetical protein LOC684862
(LOC684862), mRNA [XM_001072231]




A_44_P472974 Masp1 NM_022257 0.28 0.0005 0.0394 refjRattus norvegicus mannan-binding
lectin serine peptidase 1 (Masp1),
mRNA [NM_022257]
A_44_P510188 TC618566 TC618566 0.28 0.0014 0.0659 gbjAW143279 EST293575 Normalized
rat brain, Bento Soares Rattus sp. cDNA
clone RGIBJ29 50 end, mRNA sequence
[AW143279]
A_42_P485589 Map2k5 NM_017246 0.28 0.0035 0.0905 refjRattus norvegicus mitogen activated
protein kinase 5 (Map2k5), transcript
variant 2, mRNA [NM_017246]
A_44_P804257 FQ214033 FQ214033 0.28 0.0017 0.0707 gbjRattus norvegicus TL0AAA44YD13
mRNA sequence. [FQ214033]
A_44_P245087 RGD1565247 FQ211597 0.28 0.0006 0.0421 gbjRattus norvegicus TL0AAA86YF16
mRNA sequence. [FQ211597]
A_44_P433157 Clip1 NM_031745 0.27 0.0041 0.0950 refjRattus norvegicus CAP-GLY domain
containing linker protein 1 (Clip1),
mRNA [NM_031745]
A_44_P524922 NP072211 NP072211 0.27 0.0020 0.0747 tcjGBjM35258.1jAAA41564.1 malic
enzyme (EC 1.1.1.40) [NP072211]
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A_44_P313838 Lipc NM_012597 0.27 0.0033 0.0890 refjRattus norvegicus lipase, hepatic
(Lipc), mRNA [NM_012597]
A_44_P335703 Toag1 NM_001110838 0.27 0.0030 0.0863 refjRattus norvegicus tolerance-
associated gene 1 (Toag1), mRNA
[NM_001110838]
A_42_P707992 Tspan18 NM_001107750 0.27 0.0002 0.0247 refjRattus norvegicus tetraspanin 18
(Tspan18), mRNA [NM_001107750]
A_44_P149734 Hat1 NM_001009657 0.27 0.0010 0.0554 refjRattus norvegicus histone
acetyltransferase 1 (Hat1), mRNA
[NM_001009657]
A_44_P363229 Grk5 NM_030829 0.27 0.0012 0.0599 refjRattus norvegicus G protein-coupled
receptor kinase 5 (Grk5), mRNA
[NM_030829]
A_43_P10301 Esd NM_001106051 0.27 0.0006 0.0418 refjRattus norvegicus esterase D (Esd),
mRNA [NM_001106051]
A_44_P453874 Rpl7 NM_001100534 0.27 0.0012 0.0623 refjRattus norvegicus ribosomal protein
L7 (Rpl7), mRNA [NM_001100534]
A_44_P253108 Spc25 NM_001009654 0.27 0.0037 0.0920 refjRattus norvegicus SPC25, NDC80
kinetochore complex component,
homolog (S. cerevisiae) (Spc25), mRNA
[NM_001009654]
A_44_P142029 Nenf NM_001002851 0.27 0.0026 0.0814 refjRattus norvegicus neudesin
neurotrophic factor (Nenf), mRNA
[NM_001002851]
A_42_P552341 Sorl1 NM_053519 0.27 0.0006 0.0418 refjRattus norvegicus sortilin-related
receptor, LDLR class A repeats-
containing (Sorl1), mRNA [NM_053519]
A_44_P1046097 RGD1306063 NM_001106026 0.27 0.0024 0.0784 refjRattus norvegicus similar to HT021
(RGD1306063), mRNA
[NM_001106026]
A_44_P338864 Nap1l1 NM_053561 0.27 0.0005 0.0408 refjRattus norvegicus nucleosome
assembly protein 1-like 1 (Nap1l1),
mRNA [NM_053561]
A_44_P1051042 C8g NM_001106555 0.27 0.0029 0.0851 refjRattus norvegicus complement
component 8, gamma polypeptide
(C8g), mRNA [NM_001106555]
A_44_P382727 RGD1566215 NM_001106929 0.27 0.0031 0.0876 refjRattus norvegicus similar to
Coatomer gamma-2 subunit (Gamma-2
coat protein) (Gamma-2 COP)
(RGD1566215), mRNA
[NM_001106929]
A_44_P900672 Robo2 NM_032106 0.27 0.0016 0.0684 refjRattus norvegicus roundabout
homolog 2 (Drosophila) (Robo2), mRNA
[NM_032106]




A_44_P554799 Rab11a NM_031152 0.27 0.0002 0.0268 refjRattus norvegicus RAB11a, member
RAS oncogene family (Rab11a), mRNA
[NM_031152]
A_44_P784011 TC639313 TC639313 0.26 0.0020 0.0752 Unknown
A_44_P430989 Fnbp1 NM_138914 0.26 0.0003 0.0307 refjRattus norvegicus formin binding
protein 1 (Fnbp1), mRNA [NM_138914]
A_44_P411919 Psmd1 NM_031978 0.26 0.0009 0.0541 refjRattus norvegicus proteasome
(prosome, macropain) 26S subunit,
non-ATPase, 1 (Psmd1), mRNA
[NM_031978]




A_44_P407849 Nphp1 NM_001106506 0.26 0.0002 0.0223 refjRattus norvegicus nephronophthisis
1 (juvenile) homolog (human) (Nphp1),
mRNA [NM_001106506]




A_44_P220256 Prtfdc1 NM_001106127 0.26 0.0036 0.0911 refjRattus norvegicus phosphoribosyl
transferase domain containing 1
(Prtfdc1), mRNA [NM_001106127]
A_44_P389072 Il13ra1 NM_145789 0.26 0.0000 0.0106 refjRattus norvegicus interleukin 13
receptor, alpha 1 (Il13ra1), mRNA
[NM_145789]
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A_44_P351898 Mad2l1 NM_001106594 0.26 0.0015 0.0665 refjRattus norvegicus MAD2 mitotic
arrest deﬁcient-like 1 (yeast) (Mad2l1),
mRNA [NM_001106594]
A_44_P915588 LOC365723 XR_086165 0.26 0.0030 0.0854 refjPREDICTED: Rattus norvegicus
similar to zinc ﬁnger protein 458
(LOC365723), miscRNA [XR_086165]
A_43_P17528 Akr1e2 NM_001008342 0.26 0.0031 0.0872 refjRattus norvegicus aldo-keto
reductase family 1, member E2
(Akr1e2), mRNA [NM_001008342]
A_44_P226881 Pde2a NM_031079 0.26 0.0035 0.0896 refjRattus norvegicus
phosphodiesterase 2A, cGMP-
stimulated (Pde2a), transcript variant 2,
mRNA [NM_031079]
A_44_P991376 Orc3 NM_001025282 0.26 0.0023 0.0777 refjRattus norvegicus origin recognition
complex, subunit 3 (Orc3), mRNA
[NM_001025282]




A_44_P747071 Vav3 NM_001191714 0.26 0.0025 0.0802 refjRattus norvegicus vav 3 guanine
nucleotide exchange factor (Vav3),
mRNA [NM_001191714]
A_42_P726132 Tmem62 XM_230497 0.26 0.0020 0.0748 refjPREDICTED: Rattus norvegicus
transmembrane protein 62 (Tmem62),
mRNA [XM_230497]
A_44_P540126 Pros1 NM_031086 0.25 0.0032 0.0884 refjRattus norvegicus protein S (alpha)
(Pros1), mRNA [NM_031086]
A_42_P639047 RGD1309350 NM_001134507 0.25 0.0016 0.0689 refjRattus norvegicus similar to
transthyretin (4L369) (RGD1309350),
mRNA [NM_001134507]
A_44_P242756 Pcna NM_022381 0.25 0.0014 0.0657 refjRattus norvegicus proliferating cell
nuclear antigen (Pcna), mRNA
[NM_022381]
A_44_P1014445 Zfp259 NM_001137646 0.25 0.0009 0.0538 refjRattus norvegicus zinc ﬁnger protein
259 (Zfp259), mRNA [NM_001137646]
A_42_P670901 Ccdc120 FQ211363 0.25 0.0011 0.0593 gbjRattus norvegicus TL0ABA12YD13
mRNA sequence. [FQ211363]
A_44_P445359 Pex7 NM_001034147 0.25 0.0007 0.0467 refjRattus norvegicus peroxisomal
biogenesis factor 7 (Pex7), mRNA
[NM_001034147]




A_44_P231719 Tmem9b NM_001106289 0.25 0.0009 0.0545 refjRattus norvegicus TMEM9 domain
family, member B (Tmem9b), mRNA
[NM_001106289]
A_43_P13342 Gstp1 NM_012577 0.25 0.0036 0.0909 refjRattus norvegicus glutathione S-
transferase pi 1 (Gstp1), mRNA
[NM_012577]
A_44_P508924 LOC691594 XM_001078957 0.25 0.0010 0.0547 refjPREDICTED: Rattus norvegicus
similar to hypothetical protein
LOC501396 (LOC691594), mRNA
[XM_001078957]
A_43_P18931 RGD1304982 NM_001113775 0.25 0.0027 0.0821 refjRattus norvegicus similar to RIKEN
cDNA 2810025M15 (RGD1304982),
mRNA [NM_001113775]
A_44_P260055 Gyg1 NM_031043 0.25 0.0021 0.0763 refjRattus norvegicus glycogenin 1
(Gyg1), mRNA [NM_031043]
A_44_P792333 TC598219 TC598219 0.25 0.0004 0.0359 tcjCD59_RAT (P27274) CD59
glycoprotein precursor (Membrane




A_44_P237220 Ttc13 NM_001136162 0.24 0.0036 0.0911 refjRattus norvegicus tetratricopeptide
repeat domain 13 (Ttc13), mRNA
[NM_001136162]
A_42_P586064 Pacs1 NM_134406 0.24 0.0020 0.0752 refjRattus norvegicus phosphofurin
acidic cluster sorting protein 1 (Pacs1),
mRNA [NM_134406]
A_43_P16992 Auh NM_001108407 0.24 0.0005 0.0406 refjRattus norvegicus AU RNA binding
protein/enoyl-CoA hydratase (Auh),
nuclear gene encoding mitochondrial
protein, mRNA [NM_001108407]
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A_44_P380343 XM_217443 XM_217443 0.24 0.0003 0.0275 gbjRattus norvegicus similar to
4833408P15Rik protein (LOC301525),
mRNA [XM_217443]
A_44_P689118 CO402250 CO402250 0.24 0.0040 0.0941 gbjAGENCOURT_27852273
NIH_MGC_252 Rattus norvegicus cDNA
clone IMAGE:7306766 50 , mRNA
sequence [CO402250]
A_44_P434893 Hspb11 NM_001131002 0.24 0.0023 0.0777 refjRattus norvegicus heat shock
protein family B (small), member 11
(Hspb11), mRNA [NM_001131002]
A_44_P405360 Spryd7 NM_001009635 0.24 0.0011 0.0582 refjRattus norvegicus SPRY domain
containing 7 (Spryd7), mRNA
[NM_001009635]
A_44_P792035 Mcart1 NM_001024785 0.24 0.0018 0.0716 refjRattus norvegicus mitochondrial
carrier triple repeat 1 (Mcart1), nuclear
gene encoding mitochondrial protein,
mRNA [NM_001024785]
A_43_P17839 Prkra NM_001024780 0.24 0.0012 0.0623 refjRattus norvegicus protein kinase,
interferon inducible double stranded
RNA dependent activator (Prkra), mRNA
[NM_001024780]
A_44_P379951 Rnf170 XM_344558 0.23 0.0030 0.0862 refjPREDICTED: Rattus norvegicus ring
ﬁnger protein 170 (Rnf170), mRNA
[XM_344558]
A_43_P22401 Lrrc51 NM_001106284 0.23 0.0010 0.0546 refjRattus norvegicus leucine rich
repeat containing 51 (Lrrc51), mRNA
[NM_001106284]
A_44_P154436 Tnfaip8 NM_001107387 0.23 0.0038 0.0931 refjRattus norvegicus tumor necrosis
factor, alpha-induced protein 8
(Tnfaip8), mRNA [NM_001107387]
A_42_P547027 Fuca2 NM_001004218 0.23 0.0044 0.0991 refjRattus norvegicus fucosidase, alpha-
L-2, plasma (Fuca2), mRNA
[NM_001004218]
A_44_P534249 Ociad1 NM_001013874 0.23 0.0010 0.0553 refjRattus norvegicus OCIA domain
containing 1 (Ociad1), mRNA
[NM_001013874]




A_44_P435016 Nudt2 NM_207596 0.23 0.0004 0.0354 refjRattus norvegicus nudix (nucleoside
diphosphate linked moiety X)-type
motif 2 (Nudt2), mRNA [NM_207596]
A_44_P311969 XM_342996 XM_342996 0.23 0.0015 0.0665 gbjRattus norvegicus similar to
hypothetical protein FLJ90811
(LOC362681), mRNA [XM_342996]




A_43_P16611 Usp9x NM_001135893 0.23 0.0010 0.0554 refjRattus norvegicus ubiquitin speciﬁc
peptidase 9, X-linked (Usp9x),
transcript variant 1, mRNA
[NM_001135893]
A_44_P1044046 Ndufaf1 NM_001106500 0.23 0.0040 0.0941 refjRattus norvegicus NADH
dehydrogenase (ubiquinone) 1 alpha
subcomplex, assembly factor 1
(Ndufaf1), mRNA [NM_001106500]
A_44_P235462 AI029293 AI029293 0.22 0.0018 0.0713 gbjAI029293 UI-R-C0-iq-f-03-0-UI.s1
UI-R-C0 Rattus norvegicus cDNA clone
UI-R-C0-iq-f-03-0-UI 30 , mRNA
sequence [AI029293]
A_43_P17077 Mettl10 NM_001108504 0.22 0.0035 0.0899 refjRattus norvegicus
methyltransferase like 10 (Mettl10),
mRNA [NM_001108504]
A_44_P432452 Akr1b1 NM_012498 0.22 0.0008 0.0520 refjRattus norvegicus aldo-keto
reductase family 1, member B1 (aldose
reductase) (Akr1b1), mRNA
[NM_012498]
A_44_P175751 Dip2a NM_001191564 0.22 0.0020 0.0752 refjRattus norvegicus DIP2 disco-
interacting protein 2 homolog A
(Drosophila) (Dip2a), mRNA
[NM_001191564]
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A_44_P500653 Nicn1 NM_001034999 0.22 0.0024 0.0789 refjRattus norvegicus nicolin 1 (Nicn1),
mRNA [NM_001034999]
A_43_P20902 Donson NM_001008287 0.22 0.0003 0.0298 refjRattus norvegicus downstream
neighbor of SON (Donson), mRNA
[NM_001008287]
A_44_P160545 DV725496 DV725496 0.22 0.0033 0.0891 gbjRVL17676 Wackym-Soares
normalized rat vestibular cDNA library
Rattus norvegicus cDNA 50 , mRNA
sequence [DV725496]
A_44_P971443 TC623207 TC623207 0.22 0.0025 0.0792 gbjAW918781 EST350085 Rat gene
index, normalized rat, norvegicus,
Bento Soares Rattus norvegicus cDNA
clone RGIEY05 50 end, mRNA sequence
[AW918781]
A_44_P299500 Gmpr2 NM_001013036 0.22 0.0037 0.0928 refjRattus norvegicus guanosine
monophosphate reductase 2 (Gmpr2),
mRNA [NM_001013036]
A_44_P434541 Ada NM_130399 0.22 0.0040 0.0943 refjRattus norvegicus adenosine
deaminase (Ada), mRNA [NM_130399]
A_44_P1025802 Metap1 NM_001106476 0.21 0.0018 0.0713 refjRattus norvegicus methionyl
aminopeptidase 1 (Metap1), mRNA
[NM_001106476]
A_42_P756393 TC589591 TC589591 0.21 0.0025 0.0795 gbjAW920459 EST351763 Rat gene
index, normalized rat, norvegicus,
Bento Soares Rattus norvegicus cDNA
clone RGIGW54 50 end, mRNA sequence
[AW920459]
A_44_P1058112 Yars2 NM_001009627 0.21 0.0041 0.0956 refjRattus norvegicus tyrosyl-tRNA
synthetase 2 (mitochondrial) (Yars2),
nuclear gene encoding mitochondrial
protein, mRNA [NM_001009627]
A_44_P147426 Nt5dc1 NM_001106393 0.21 0.0021 0.0762 refjRattus norvegicus 50-nucleotidase
domain containing 1 (Nt5dc1), mRNA
[NM_001106393]
A_44_P1036696 Napg NM_001107384 0.21 0.0011 0.0591 refjRattus norvegicus N-
ethylmaleimide-sensitive factor
attachment protein, gamma (Napg),
mRNA [NM_001107384]
A_44_P499318 LOC294154 NM_001039607 0.21 0.0021 0.0763 refjRattus norvegicus similar to
chromosome 6 open reading frame 106
isoform a (LOC294154), mRNA
[NM_001039607]




A_44_P329925 Vps37b NM_001105928 0.21 0.0007 0.0490 refjRattus norvegicus vacuolar protein
sorting 37 homolog B (S. cerevisiae)
(Vps37b), mRNA [NM_001105928]
A_44_P144871 Coq4 NM_001031662 0.21 0.0028 0.0840 refjRattus norvegicus coenzyme Q4
homolog (S. cerevisiae) (Coq4), nuclear
gene encoding mitochondrial protein,
mRNA [NM_001031662]
A_44_P377731 Pef1 NM_001007651 0.21 0.0008 0.0521 refjRattus norvegicus penta-EF hand
domain containing 1 (Pef1), mRNA
[NM_001007651]
A_43_P20851 Ppﬁbp2 NM_001100582 0.21 0.0034 0.0896 refjRattus norvegicus PTPRF interacting
protein, binding protein 2 (liprin beta 2)
(Ppﬁbp2), mRNA [NM_001100582]
A_44_P249902 Vps29 NM_001105932 0.21 0.0006 0.0436 refjRattus norvegicus vacuolar protein
sorting 29 homolog (S. cerevisiae)
(Vps29), mRNA [NM_001105932]
A_44_P182336 Tanc1 NM_001002854 0.21 0.0006 0.0436 refjRattus norvegicus tetratricopeptide
repeat, ankyrin repeat and coiled-coil
containing 1 (Tanc1), mRNA
[NM_001002854]




A_44_P505694 Cyp20a1 NM_199401 0.20 0.0042 0.0966 refjRattus norvegicus cytochrome P450,
family 20, subfamily a, polypeptide 1
(Cyp20a1), mRNA [NM_199401]
A_43_P15601 Mat2a NM_134351 0.20 0.0038 0.0931 refjRattus norvegicus methionine
adenosyltransferase II, alpha (Mat2a),
mRNA [NM_134351]
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A_44_P1008284 TC575338 TC575338 0.20 0.0031 0.0876 tcjDCTN4_RAT (Q9QUR2) Dynactin
subunit 4 (Dynactin subunit p62),
complete [TC575338]
A_44_P463679 Zpbp2 NM_001007011 0.20 0.0016 0.0684 refjRattus norvegicus zona pellucida
binding protein 2 (Zpbp2), mRNA
[NM_001007011]
A_44_P457833 Trim32 NM_001012103 0.20 0.0013 0.0631 refjRattus norvegicus tripartite motif-
containing 32 (Trim32), mRNA
[NM_001012103]
A_44_P330197 Srpk3 NM_184045 0.19 0.0032 0.0876 refjRattus norvegicus SRSF protein
kinase 3 (Srpk3), mRNA [NM_184045]




A_43_P18283 March6 XM_215517 0.18 0.0019 0.0739 refjPREDICTED: Rattus norvegicus
membrane-associated ring ﬁnger
(C3HC4) 6 (March6), mRNA
[XM_215517]
A_44_P234212 Olfml3 NM_001107708 0.18 0.0014 0.0649 refjRattus norvegicus olfactomedin-like
3 (Olfml3), mRNA [NM_001107708]
A_44_P152017 FQ227332 FQ227332 0.18 0.0037 0.0919 gbjRattus norvegicus TL0AEA13YL20
mRNA sequence. [FQ227332]
A_44_P409232 Cyp2e1 NM_031543 0.17 0.0025 0.0796 refjRattus norvegicus cytochrome P450,
family 2, subfamily e, polypeptide 1
(Cyp2e1), mRNA [NM_031543]
A_44_P1042504 Rg9mtd2 NM_001044232 0.16 0.0031 0.0876 refjRattus norvegicus RNA (guanine-9-)
methyltransferase domain containing 2
(Rg9mtd2), mRNA [NM_001044232]
A_44_P161579 Haus2 XM_001053441 0.16 0.0037 0.0928 refjPREDICTED: Rattus norvegicus
HAUS augmin-like complex, subunit 2,
transcript variant 1 (Haus2), mRNA
[XM_001053441]




B.B. Roques et al. / Biochemical Pharmacology 86 (2013) 997–1039 1017one-compartment model with a ﬁrst-order absorption rate using
the following equation:
CðtÞ ¼ F  D  K01
V  ðK01  K10Þ  ðexpðK10  tÞ  expðK01  tÞÞ;
where C(t) is the plasma concentration at time t (ng/mL), F is the
bioavailability of the drug, D is the drug dose (mg/kg), V is the
volume of distribution (mL/kg), K01 is the ﬁrst-order rate constant
of absorption (h1) and K10 is the ﬁrst-order rate constant of
elimination (h1). The data were weighted by the inverse of the
ﬁtted values. The apparent clearance was deﬁned as dose/AUC.
2.7. Statistical analysis
Data were analyzed under R (R1 2.13.0, www.r-project.org).
Microarray data were analyzed using packages from Bioconductor
(www.bioconductor.org). Details of microarray data analysis,
together with raw and processed microarray data can be found in
GEO entry GSE39378. Differentially expressed probes were identi-
ﬁed using the limma and q-value packages. Probes with a q-
value  0.1wereconsideredsigniﬁcant.Allother data wereanalyzed
byANOVAwiththe appropriatefactorsasﬁxedeffects(dependingon
the experimental design: treatment, genotype and their interaction)
followed by Student’s t-test with a pooled variance estimate to
compare the group’s means. Data are presented as mean  SEM.
3. Results
3.1. Impact of ﬁpronil on rat liver transcriptome
Consistent with our previous observations [5], female rats
treated with ﬁpronil via oral route (3 mg/kg per day, 14 days)displayed plasma concentrations of its main metabolite ﬁpronil
sulfone at least 700-fold higher than those of ﬁpronil itself
(Fig. 1A). Fipronil had no effect on body weight gain throughout the
experiment (data not shown) and the animals did not display any
overt sign of toxicity. As previously reported [4], ﬁpronil treatment
was associated with reduced plasma thyroid hormone (TH) levels
(Fig. 1B) although only the decrease in total T4 clearly approached
signiﬁcance (p = 0.06). We have previously shown using a model of
T3-supplemented thyroidectomized rats that this effect of ﬁpronil
is linked to an increase in TH clearance [4]. Consistent with an
increased TH clearance which could be compensated by feedback
induction of TH synthesis, ﬁpronil treatment led to a signiﬁcant
increase in plasma TSH (p < 0.05, Fig. 1C).
The liver plays a central role in the metabolism of ﬁpronil
[7,16] and of thyroid hormones [17,18]. To explore the main
impacts of ﬁpronil treatment in the liver, we used Agilent
microarrays to analyze the hepatic transcriptome of vehicle-
(n = 7) and ﬁpronil-treated rats (n = 8). Following ﬁpronil
treatment we found 402 upregulated probes (377 unique genes,
Table 2) and 310 downregulated probes (292 unique genes,
Table 3) using a FDR threshold of 10% (q-value < 0.1, which
corresponds to raw p-value < 0.0045). The clear impact of ﬁpronil
on the liver transcriptome is illustrated by the heatmap and
hierarchical clustering obtained from these 712 probes which
captured differential gene expression (Fig. 2A). The tests for the
enrichment of gene ontology (GO) biological processes revealed
that functions linked to the metabolism and transport of
xenobiotics, hormones and endogenous compounds such as bile
acids or steroids were over-represented among the upregulated
genes (Fig. 2A and Table 4). Interestingly, this analysis also
identiﬁed the over-representation of thyroid hormone transpor-
ters among the upregulated genes. Conversely, functions linked
Table 3
Genes signiﬁcantly downregulated in rat liver following ﬁpronil treatment (q-value < 0.1).
ProbeName GeneName SystematicName log 2 (FIP/CTRL) p-value q-value Description
A_44_P204758 Sult4a1 NM_031641 1.82 0.0000 0.0014 refjRattus norvegicus sulfotransferase
family 4A, member 1 (Sult4a1), mRNA
[NM_031641]








A_44_P904150 TC617637 TC617637 0.59 0.0000 0.0051 Unknown




A_44_P236670 LOC691410 XM_001078125 0.59 0.0000 0.0056 refjPREDICTED: Rattus norvegicus
similar to Discs large homolog 5
(Placenta and prostate DLG) (Discs large
protein P-dlg) (LOC691410), mRNA
[XM_001078125]





A_44_P757007 Bmp1 NM_031323 0.44 0.0000 0.0074 refjRattus norvegicus bone
morphogenetic protein 1 (Bmp1),
mRNA [NM_031323]
A_44_P378799 Igfbp6 NM_013104 0.72 0.0000 0.0075 refjRattus norvegicus insulin-like
growth factor binding protein 6
(Igfbp6), mRNA [NM_013104]
A_44_P468902 XM_226288 XM_226288 0.50 0.0000 0.0093 gbjRattus norvegicus similar to RIKEN
cDNA 1700081O22 (LOC307681),
mRNA [XM_226288]
A_43_P22318 Prss32 NM_001106983 0.47 0.0000 0.0094 refjRattus norvegicus protease, serine,
32 (Prss32), mRNA [NM_001106983]
A_44_P541505 XM_226288 XM_226288 0.92 0.0000 0.0104 gbjRattus norvegicus similar to RIKEN
cDNA 1700081O22 (LOC307681),
mRNA [XM_226288]
A_44_P247219 Cited4 NM_053699 0.75 0.0000 0.0116 refjRattus norvegicus Cbp/p300-
interacting transactivator, with Glu/
Asp-rich carboxy-terminal domain, 4
(Cited4), mRNA [NM_053699]
A_44_P253380 RGD1563738 XM_345920 0.80 0.0000 0.0116 gbjRattus norvegicus similar to RIKEN
cDNA 1700081O22 (LOC367059),
mRNA [XM_345920]
A_43_P13418 Kcnk2 NM_172042 1.62 0.0000 0.0120 refjRattus norvegicus potassium
channel, subfamily K, member 2
(Kcnk2), transcript variant 2, mRNA
[NM_172042]
A_44_P727508 TC594987 TC594987 0.43 0.0001 0.0135 gbjBF281819 EST446410 Rat Gene
Index, normalized rat, Rattus
norvegicus cDNA Rattus norvegicus
cDNA clone RGIBD05, mRNA sequence
[BF281819]




A_44_P220821 AW532611 AW532611 0.26 0.0001 0.0149 gbjAW532611 UI-R-BS0-amp-e-02-0-
UI.s1 UI-R-BS0 Rattus norvegicus cDNA
clone UI-R-BS0-amp-e-02-0-UI 30 ,
mRNA sequence [AW532611]
A_44_P1042234 Stmn3 NM_024346 0.41 0.0001 0.0151 refjRattus norvegicus stathmin-like 3
(Stmn3), mRNA [NM_024346]
A_44_P210486 Atp5g1 NM_017311 0.31 0.0001 0.0160 refjRattus norvegicus ATP synthase, H+
transporting, mitochondrial F0
complex, subunit C1 (subunit 9)
(Atp5g1), nuclear gene encoding
mitochondrial protein, mRNA
[NM_017311]
A_42_P808456 Disp1 NM_001105983 0.41 0.0001 0.0160 refjRattus norvegicus dispatched
homolog 1 (Drosophila) (Disp1), mRNA
[NM_001105983]
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A_44_P865620 TC591379 TC591379 0.74 0.0001 0.0160 tcjQ9JJ03_RAT (Q9JJ03) Angiotensin II
type 1A receptor associated protein,
complete [TC591379]
A_44_P268395 AA943735 AA943735 0.33 0.0001 0.0164 gbjAA943735 EST199234 Normalized
rat brain, Bento Soares Rattus sp. cDNA
clone RBRAP04 30 end, mRNA sequence
[AA943735]
A_44_P148699 AA955748 AA955748 0.27 0.0001 0.0180 gbjAA955748 UI-R-E1-fg-d-10-0-UI.s1
UI-R-E1 Rattus norvegicus cDNA clone
UI-R-E1-fg-d-10-0-UI 30 similar to gi
[AA955748]
A_44_P884766 RGD1561849 NM_001109260 0.76 0.0001 0.0180 refjRattus norvegicus similar to RIKEN
cDNA 3110035E14 (RGD1561849),
mRNA [NM_001109260]
A_42_P540711 Rasd2 NM_133568 1.16 0.0001 0.0201 refjRattus norvegicus RASD family,
member 2 (Rasd2), mRNA
[NM_133568]
A_44_P126564 Mon1a NM_001126284 0.35 0.0001 0.0209 refjRattus norvegicus MON1 homolog A
(yeast) (Mon1a), mRNA
[NM_001126284]
A_42_P820829 Oaf NM_001014090 0.44 0.0001 0.0217 refjRattus norvegicus OAF homolog
(Drosophila) (Oaf), mRNA
[NM_001014090]




A_43_P15784 Cyp4a3 NM_175760 0.73 0.0002 0.0229 refjRattus norvegicus cytochrome P450,
family 4, subfamily a, polypeptide 3
(Cyp4a3), mRNA [NM_175760]
A_44_P466189 Angptl2 NM_133569 0.92 0.0002 0.0231 refjRattus norvegicus angiopoietin-like
2 (Angptl2), mRNA [NM_133569]




A_44_P175349 Crispld2 NM_138518 0.69 0.0002 0.0235 refjRattus norvegicus cysteine-rich
secretory protein LCCL domain
containing 2 (Crispld2), mRNA
[NM_138518]
A_44_P118531 AW919008 AW919008 0.22 0.0002 0.0235 gbjAW919008 EST350312 Rat gene
index, normalized rat, norvegicus,
Bento Soares Rattus norvegicus cDNA
clone RGIFB53 50 end, mRNA sequence
[AW919008]




A_44_P169574 AI045802 AI045802 0.22 0.0002 0.0247 gbjAI045802 UI-R-C0-jq-c-07-0-UI.s2
UI-R-C0 Rattus norvegicus cDNA clone
UI-R-C0-jq-c-07-0-UI 30 , mRNA
sequence [AI045802]
A_43_P11040 Tppp3 NM_001009639 0.81 0.0002 0.0247 refjRattus norvegicus tubulin
polymerization-promoting protein
family member 3 (Tppp3), mRNA
[NM_001009639]
A_44_P523028 XM_344727 XM_344727 0.45 0.0002 0.0266 gbjRattus norvegicus similar to RIKEN
cDNA 4933431D05 (LOC364949),
mRNA [XM_344727]
A_44_P426478 XM_239603 XM_239603 0.33 0.0002 0.0266 gbjRattus norvegicus similar to RIKEN
cDNA 1300006M19 (LOC304282),
mRNA [XM_239603]
A_44_P370229 Fam20c NM_001012238 0.47 0.0002 0.0266 refjRattus norvegicus family with
sequence similarity 20, member C
(Fam20c), mRNA [NM_001012238]




A_44_P356738 LOC501080 XM_576492 0.51 0.0002 0.0275 refjPREDICTED: Rattus norvegicus
similar to Discs large homolog 5
(Placenta and prostate DLG) (Discs large
protein P-dlg) (LOC501080), mRNA
[XM_576492]
A_44_P1034201 Lamb3 NM_001100841 0.52 0.0002 0.0275 refjRattus norvegicus laminin, beta 3
(Lamb3), mRNA [NM_001100841]
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A_44_P365516 Tsc22d1 NM_013043 0.75 0.0002 0.0275 refjRattus norvegicus TSC22 domain
family, member 1 (Tsc22d1), transcript
variant 2, mRNA [NM_013043]
A_42_P721270 Nﬁx NM_030866 0.36 0.0003 0.0275 refjRattus norvegicus nuclear factor I/X
(CCAAT-binding transcription factor)
(Nﬁx), mRNA [NM_030866]
A_44_P298934 BE116552 BE116552 0.49 0.0003 0.0275 gbjBE116552 UI-R-BS1-ayj-e-12-0-
UI.s1 UI-R-BS1 Rattus norvegicus cDNA
clone UI-R-BS1-ayj-e-12-0-UI 30 , mRNA
sequence [BE116552]
A_44_P1038885 Slc16a13 NM_001005530 1.05 0.0003 0.0287 refjRattus norvegicus solute carrier
family 16, member 13 (monocarboxylic
acid transporter 13) (Slc16a13), mRNA
[NM_001005530]
A_44_P390265 AA858718 AA858718 0.25 0.0003 0.0298 gbjAA858718 UI-R-A0-be-b-04-0-UI.s1
UI-R-A0 Rattus norvegicus cDNA clone
UI-R-A0-be-b-04-0-UI 30 similar to emb
[AA858718]
A_44_P861558 Ncor2 NM_001108334 0.29 0.0003 0.0298 refjRattus norvegicus nuclear receptor
co-repressor 2 (Ncor2), mRNA
[NM_001108334]
A_42_P706831 RGD1562079 NM_001177687 0.31 0.0003 0.0298 refjRattus norvegicus RGD1562079
(RGD1562079), mRNA
[NM_001177687]
A_44_P397472 BQ205131 BQ205131 0.37 0.0003 0.0298 gbjBQ205131 UI-R-DZ1-cnh-f-09-0-
UI.s1 NCI_CGAP_DZ1 Rattus norvegicus
cDNA clone IMAGE:7345643 30 , mRNA
sequence [BQ205131]




A_43_P14977 Tsc22d1 NM_001109912 0.68 0.0003 0.0298 refjRattus norvegicus TSC22 domain
family, member 1 (Tsc22d1), transcript
variant 1, mRNA [NM_001109912]
A_42_P533312 Pc NM_012744 0.46 0.0003 0.0305 refjRattus norvegicus pyruvate
carboxylase (Pc), nuclear gene encoding
mitochondrial protein, mRNA
[NM_012744]
A_44_P553424 Pnpla5 NM_001130497 1.45 0.0003 0.0319 refjRattus norvegicus patatin-like
phospholipase domain containing 5
(Pnpla5), mRNA [NM_001130497]
A_44_P482700 Ttyh1 NM_001106225 0.18 0.0004 0.0326 refjRattus norvegicus tweety homolog 1
(Drosophila) (Ttyh1), mRNA
[NM_001106225]
A_44_P277923 AI072634 AI072634 0.49 0.0004 0.0326 gbjAI072634 UI-R-C2-nn-f-11-0-UI.s1
UI-R-C2 Rattus norvegicus cDNA clone
UI-R-C2-nn-f-11-0-UI 30 , mRNA
sequence [AI072634]




A_43_P18344 Ripk2 NM_001191865 0.27 0.0004 0.0375 refjRattus norvegicus receptor-
interacting serine-threonine kinase 2
(Ripk2), mRNA [NM_001191865]
A_44_P653701 Mybl2 NM_001106536 0.29 0.0004 0.0375 refjRattus norvegicus myeloblastosis
oncogene-like 2 (Mybl2), mRNA
[NM_001106536]




A_44_P1033661 Prpf3 NM_001108559 0.25 0.0005 0.0396 refjRattus norvegicus PRP3 pre-mRNA
processing factor 3 homolog (S.
cerevisiae) (Prpf3), mRNA
[NM_001108559]
A_42_P735495 Cyp4a8 NM_031605 0.83 0.0005 0.0400 refjRattus norvegicus cytochrome P450,
family 4, subfamily a, polypeptide 8
(Cyp4a8), mRNA [NM_031605]
A_44_P776188 Actr1b NM_001039028 0.29 0.0005 0.0406 refjRattus norvegicus ARP1 actin-
related protein 1 homolog B (yeast)
(Actr1b), mRNA [NM_001039028]
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A_44_P516940 BF281337 BF281337 0.34 0.0005 0.0406 gbjBF281337 EST445928 Rat Gene
Index, normalized rat, Rattus
norvegicus cDNA Rattus norvegicus
cDNA clone RGIAD41 30 sequence,
mRNA sequence [BF281337]
A_42_P462379 TC593865 TC593865 0.39 0.0005 0.0409 tcjQ3H6G1_9ACTO (Q3H6G1)
Regulatory protein, LuxR:Metal-
dependent phosphohydrolase, HD
subdomain, partial (3%) [TC593865]
A_44_P200630 AA851208 AA851208 0.31 0.0006 0.0418 gbjAA851208 EST193976 Normalized
rat placenta, Bento Soares Rattus sp.
cDNA clone RPLAD82 30 end, mRNA
sequence [AA851208]
A_44_P699211 A_44_P699211 A_44_P699211 0.32 0.0006 0.0420 Unknown
A_44_P447222 AA956633 AA956633 0.36 0.0006 0.0421 gbjAA956633 UI-R-E1-fn-g-02-0-UI.s1
UI-R-E1 Rattus norvegicus cDNA clone
UI-R-E1-fn-g-02-0-UI 30 similar to gi
[AA956633]




A_44_P433431 Hist1h2an NM_001107354 0.28 0.0006 0.0444 refjRattus norvegicus histone cluster 1,
H2an (Hist1h2an), mRNA
[NM_001107354]
A_43_P11369 RGD1304792 NM_001134554 0.28 0.0006 0.0452 refjRattus norvegicus similar to
chromosome 2 open reading frame 3;
transcription factor 9 (binds GC-rich
sequences) (RGD1304792), mRNA
[NM_001134554]
A_44_P146616 Hist3h2a NM_021840 0.32 0.0007 0.0463 gbjRattus norvegicus histone 2a (H2a),
mRNA [NM_021840]
A_44_P342451 Rpp38 NM_001033063 0.51 0.0007 0.0463 refjRattus norvegicus ribonuclease P/
MRP 38 subunit (human) (Rpp38),
mRNA [NM_001033063]
A_44_P226050 BM391860 BM391860 0.27 0.0007 0.0469 gbjBM391860 UI-R-DO1-cmk-j-12-0-
UI.s1 UI-R-DO1 Rattus norvegicus cDNA
clone UI-R-DO1-cmk-j-12-0-UI 30 ,
mRNA sequence [BM391860]
A_44_P949357 TC637337 TC637337 0.32 0.0007 0.0486 tcjQ3JMD5_BURP1 (Q3JMD5)
Hydrogenase 4 membrane component,
partial (7%) [TC637337]
A_44_P552849 Ctsh NM_012939 0.30 0.0007 0.0490 refjRattus norvegicus cathepsin H
(Ctsh), mRNA [NM_012939]
A_44_P219516 AW252650 AW252650 0.43 0.0008 0.0520 gbjAW252650 UI-R-BJ0-aeb-a-05-0-
UI.s1 UI-R-BJ0 Rattus norvegicus cDNA
clone UI-R-BJ0-aeb-a-05-0-UI 30 , mRNA
sequence [AW252650]
A_44_P711071 Smg7 NM_001191549 0.27 0.0008 0.0526 refjRattus norvegicus Smg-7 homolog,
nonsense mediated mRNA decay factor
(C. elegans) (Smg7), mRNA
[NM_001191549]
A_44_P520700 FQ234328 FQ234328 0.37 0.0008 0.0531 gbjRattus norvegicus TL0AEA59YG01
mRNA sequence. [FQ234328]




A_43_P18422 Zcchc24 NM_001108394 0.26 0.0009 0.0538 refjRattus norvegicus zinc ﬁnger, CCHC
domain containing 24 (Zcchc24), mRNA
[NM_001108394]




A_44_P869639 Setd5 NM_001106614 0.31 0.0009 0.0538 refjRattus norvegicus SET domain
containing 5 (Setd5), mRNA
[NM_001106614]
A_42_P504077 Pdxp NM_001135819 0.56 0.0009 0.0538 refjRattus norvegicus pyridoxal
(pyridoxine, vitamin B6) phosphatase
(Pdxp), mRNA [NM_001135819]
A_44_P503251 Nov NM_030868 1.92 0.0009 0.0538 refjRattus norvegicus nephroblastoma
overexpressed gene (Nov), mRNA
[NM_030868]
A_42_P600817 Trpv4 NM_023970 0.24 0.0009 0.0540 refjRattus norvegicus transient receptor
potential cation channel, subfamily V,
member 4 (Trpv4), mRNA [NM_023970]
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A_44_P375553 Lrp1 NM_001130490 0.58 0.0009 0.0541 refjRattus norvegicus low density
lipoprotein receptor-related protein 1
(Lrp1), mRNA [NM_001130490]
A_44_P593422 FQ226701 FQ226701 0.21 0.0010 0.0545 gbjRattus norvegicus TL0AEA1YL10
mRNA sequence. [FQ226701]
A_44_P649046 Lrrc20 NM_001109171 0.33 0.0009 0.0545 refjRattus norvegicus leucine rich
repeat containing 20 (Lrrc20), mRNA
[NM_001109171]
A_44_P423365 TC590043 TC590043 0.39 0.0010 0.0545 gbjAW143634 EST293930 Normalized
rat embryo, Bento Soares Rattus sp.
cDNA clone RGIBX04 50 end, mRNA
sequence [AW143634]
A_44_P334157 AI176460 AI176460 0.64 0.0010 0.0546 gbjAI176460 EST220045 Normalized
rat ovary, Bento Soares Rattus sp. cDNA
clone ROVBS08 30 end, mRNA sequence
[AI176460]
A_44_P1031421 Akap13 NM_001106271 0.25 0.0010 0.0553 refjRattus norvegicus A kinase (PRKA)
anchor protein 13 (Akap13), mRNA
[NM_001106271]
A_44_P194256 Gstt2 NM_012796 0.36 0.0010 0.0553 refjRattus norvegicus glutathione S-
transferase, theta 2 (Gstt2), mRNA
[NM_012796]




A_44_P761302 TC597117 TC597117 0.57 0.0011 0.0589 tcjQ60AM1_METCA (Q60AM1) CheW
domain protein, partial (7%)
[TC597117]
A_44_P617381 Rnf216 NM_001107122 0.27 0.0011 0.0592 refjRattus norvegicus ring ﬁnger protein
216 (Rnf216), mRNA [NM_001107122]
A_44_P1034209 Lamb3 NM_001100841 0.33 0.0011 0.0593 refjRattus norvegicus laminin, beta 3
(Lamb3), mRNA [NM_001100841]
A_44_P558992 AI137488 AI137488 0.33 0.0012 0.0611 gbjAI137488 UI-R-C2p-ol-g-11-0-UI.s1
UI-R-C2p Rattus norvegicus cDNA clone
UI-R-C2p-ol-g-11-0-UI 30 , mRNA
sequence [AI137488]
A_44_P115192 Slc5a5 NM_052983 0.37 0.0012 0.0613 refjRattus norvegicus solute carrier
family 5 (sodium iodide symporter),
member 5 (Slc5a5), mRNA
[NM_052983]
A_44_P508845 XM_216190 XM_216190 0.30 0.0012 0.0614 gbjRattus norvegicus similar to
SEPIAPTERIN REDUCTASE (SPR)
(LOC297402), mRNA [XM_216190]
A_44_P258949 Pde4b NM_017031 0.21 0.0012 0.0620 refjRattus norvegicus
phosphodiesterase 4B, cAMP speciﬁc
(Pde4b), mRNA [NM_017031]
A_44_P1014163 Gsn NM_001004080 0.36 0.0012 0.0623 refjRattus norvegicus gelsolin (Gsn),
mRNA [NM_001004080]
A_42_P463675 Itga7 NM_030842 0.45 0.0012 0.0623 refjRattus norvegicus integrin, alpha 7
(Itga7), mRNA [NM_030842]
A_44_P1036534 Paqr4 NM_001017377 0.63 0.0013 0.0625 refjRattus norvegicus progestin and
adipoQ receptor family member IV
(Paqr4), mRNA [NM_001017377]
A_44_P387934 AI070791 AI070791 0.45 0.0013 0.0626 gbjUI-R-C2-mr-d-11-0-UI.s1 UI-R-C2
Rattus norvegicus cDNA clone UI-R-C2-
mr-d-11-0-UI 30 , mRNA sequence
[AI070791]
A_44_P484512 AA924735 AA924735 0.44 0.0013 0.0631 gbjAA924735 UI-R-A1-ed-g-01-0-UI.s1
UI-R-A1 Rattus norvegicus cDNA clone
UI-R-A1-ed-g-01-0-UI 30 similar to gi
[AA924735]
A_44_P165039 Zfpm1 NM_001242627 0.36 0.0013 0.0635 refjRattus norvegicus zinc ﬁnger
protein, multitype 1 (Zfpm1), mRNA
[NM_001242627]




A_42_P562635 Tmem115 NM_001108779 0.23 0.0013 0.0640 refjRattus norvegicus transmembrane
protein 115 (Tmem115), mRNA
[NM_001108779]
A_43_P22719 Pla2g2e NM_001106696 0.25 0.0014 0.0660 refjRattus norvegicus phospholipase A2,
group IIE (Pla2g2e), mRNA
[NM_001106696]
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A_42_P475340 Fbxw5 NM_001025730 0.26 0.0014 0.0660 refjRattus norvegicus F-box and WD
repeat domain containing 5 (Fbxw5),
mRNA [NM_001025730]




A_44_P911187 AA858651 AA858651 0.43 0.0014 0.0660 gbjUI-R-A0-bf-d-04-0-UI.s1 UI-R-A0
Rattus norvegicus cDNA clone UI-R-A0-
bf-d-04-0-UI 30 similar to gb
[AA858651]
A_44_P800548 A_44_P800548 A_44_P800548 0.45 0.0014 0.0660 Unknown
A_43_P12227 Crip2 NM_022501 0.50 0.0014 0.0663 refjRattus norvegicus cysteine-rich
protein 2 (Crip2), mRNA [NM_022501]
A_44_P1004142 Lime1 NM_001108614 0.23 0.0015 0.0665 refjRattus norvegicus Lck interacting
transmembrane adaptor 1 (Lime1),
mRNA [NM_001108614]
A_44_P503552 Macrod1 NM_139337 0.37 0.0015 0.0673 refjRattus norvegicus MACRO domain
containing 1 (Macrod1), mRNA
[NM_139337]
A_44_P463345 Vkorc1 AW253787 0.50 0.0015 0.0673 gbjAW253787 UI-R-BJ0-acz-d-05-0-
UI.s1 UI-R-BJ0 Rattus norvegicus cDNA
clone UI-R-BJ0-acz-d-05-0-UI 30 , mRNA
sequence [AW253787]
A_43_P16535 Mrps34 NM_001105771 0.19 0.0015 0.0682 refjRattus norvegicus mitochondrial
ribosomal protein S34 (Mrps34),
nuclear gene encoding mitochondrial
protein, mRNA [NM_001105771]
A_44_P417303 RGD1560784 XM_343770 0.24 0.0015 0.0683 gbjRattus norvegicus similar to
hypothetical protein MGC31104
(LOC363449), mRNA [XM_343770]
A_44_P868495 TC590801 TC590801 0.27 0.0016 0.0684 tcjQ6TMY0_SCHBO (Q6TMY0) Nicotinic
acetylcholine receptor non-alpha
subunit precursor, partial (3%)
[TC590801]
A_44_P305636 AA955197 AA955197 0.22 0.0016 0.0697 gbjAA955197 UI-R-A1-du-d-02-0-UI.s1
UI-R-A1 Rattus norvegicus cDNA clone
UI-R-A1-du-d-02-0-UI 30 , mRNA
sequence [AA955197]
A_44_P905275 BG381647 BG381647 0.34 0.0017 0.0697 gbjBG381647 UI-R-CT0-bud-g-05-0-
UI.s1 UI-R-CT0 Rattus norvegicus cDNA
clone UI-R-CT0-bud-g-05-0-UI 30 ,
mRNA sequence [BG381647]
A_44_P638654 Ihh NM_053384 0.49 0.0016 0.0697 refjRattus norvegicus Indian hedgehog
(Ihh), mRNA [NM_053384]
A_44_P175376 Aldh1b1 NM_001011975 0.49 0.0016 0.0697 refjRattus norvegicus aldehyde
dehydrogenase 1 family, member B1
(Aldh1b1), nuclear gene encoding
mitochondrial protein, mRNA
[NM_001011975]








A_43_P10865 Ube2e2 NM_001108371 0.30 0.0017 0.0698 refjRattus norvegicus ubiquitin-
conjugating enzyme E2E 2 (Ube2e2),
mRNA [NM_001108371]
A_44_P674035 AW522880 AW522880 0.39 0.0017 0.0698 gbjUI-R-BO0-ahn-g-09-0-UI.s1 UI-R-
BO0 Rattus norvegicus cDNA clone UI-
R-BO0-ahn-g-09-0-UI 30 , mRNA
sequence [AW522880]
A_44_P1048380 Fam46a NM_001106844 0.45 0.0017 0.0698 refjRattus norvegicus family with
sequence similarity 46, member A
(Fam46a), mRNA [NM_001106844]
A_44_P329712 S63167 S63167 0.72 0.0017 0.0698 gbj3 beta-hydroxysteroid
dehydrogenase isomerase type II.2
[rats, liver, mRNA, 2675 nt]. [S63167]
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A_44_P387410 AA963282 AA963282 0.16 0.0018 0.0711 gbjAA963282 UI-R-E1-gh-h-06-0-UI.s1
UI-R-E1 Rattus norvegicus cDNA clone
UI-R-E1-gh-h-06-0-UI 30 , mRNA
sequence [AA963282]
A_44_P283444 Slc19a1 NM_017299 0.21 0.0018 0.0711 refjRattus norvegicus solute carrier
family 19 (folate transporter), member
1 (Slc19a1), transcript variant 1, mRNA
[NM_017299]
A_43_P22141 Foxo4 NM_001106943 0.22 0.0018 0.0711 refjRattus norvegicus forkhead box O4
(Foxo4), mRNA [NM_001106943]
A_44_P167638 AW534176 AW534176 0.28 0.0018 0.0711 gbjAW534176 UI-R-C4-alq-b-02-0-
UI.s1 UI-R-C4 Rattus norvegicus cDNA
clone UI-R-C4-alq-b-02-0-UI 30 , mRNA
sequence [AW534176]
A_44_P116346 Soat2 NM_153728 0.34 0.0017 0.0711 refjRattus norvegicus sterol O-
acyltransferase 2 (Soat2), mRNA
[NM_153728]
A_44_P433147 Gnat3 NM_173139 0.38 0.0018 0.0711 refjRattus norvegicus guanine
nucleotide binding protein, alpha
transducing 3 (Gnat3), mRNA
[NM_173139]
A_44_P592983 FM122635 FM122635 0.44 0.0018 0.0711 gbjFM122635 etnohea Rattus
norvegicus cDNA clone
etnoheaP0058C05 50 , mRNA sequence
[FM122635]
A_44_P325285 Tymp NM_001012122 1.12 0.0017 0.0711 refjRattus norvegicus thymidine
phosphorylase (Tymp), mRNA
[NM_001012122]
A_44_P999653 Tsen54 NM_001109576 0.23 0.0018 0.0713 refjRattus norvegicus tRNA splicing
endonuclease 54 homolog (S.
cerevisiae) (Tsen54), mRNA
[NM_001109576]
A_44_P554782 BF564475 BF564475 0.24 0.0019 0.0729 gbjUI-R-BU0-amt-h-03-0-UI.r1 UI-R-
BU0 Rattus norvegicus cDNA clone UI-
R-BU0-amt-h-03-0-UI 50, mRNA
sequence [BF564475]
A_44_P975167 Hist1h2an NM_001107354 0.26 0.0019 0.0729 refjRattus norvegicus histone cluster 1,
H2an (Hist1h2an), mRNA
[NM_001107354]
A_44_P151759 Cdig2 NM_153624 0.29 0.0019 0.0735 refjRattus norvegicus Cdig2 protein
(Cdig2), mRNA [NM_153624]
A_44_P179814 Gas6 NM_057100 0.48 0.0019 0.0735 refjRattus norvegicus growth arrest
speciﬁc 6 (Gas6), mRNA [NM_057100]
A_44_P620356 Cstf2t NM_001107586 0.22 0.0019 0.0735 refjRattus norvegicus cleavage
stimulation factor, 30 pre-RNA subunit
2, tau (Cstf2t), mRNA [NM_001107586]
A_44_P454763 Pcdh18 NM_001100524 0.44 0.0020 0.0747 refjRattus norvegicus protocadherin 18
(Pcdh18), mRNA [NM_001100524]
A_44_P476936 TC574523 TC574523 0.36 0.0020 0.0752 tcjAGTRA_RAT (P25095) Type-1A
angiotensin II receptor (AT1) (AT1A),
complete [TC574523]
A_44_P180980 TC621691 TC621691 0.39 0.0020 0.0752 gbjBQ209232 UI-R-DY1-cnt-c-16-0-
UI.s1 NCI_CGAP_DY1 Rattus norvegicus
cDNA clone IMAGE:7334442 30 , mRNA
sequence [BQ209232]




A_44_P615345 Llgl2 NM_001127549 0.23 0.0020 0.0758 refjRattus norvegicus lethal giant larvae
homolog 2 (Drosophila) (Llgl2), mRNA
[NM_001127549]
A_44_P976212 TC630316 TC630316 0.28 0.0021 0.0760 Unknown
A_44_P336925 CA510266 CA510266 0.26 0.0021 0.0763 gbjCA510266 UI-R-FS0-cqr-h-07-0-
UI.s1 NCI_CGAP_FS0 Rattus norvegicus
cDNA clone IMAGE:7357209 30 , mRNA
sequence [CA510266]
A_44_P207383 AI013472 AI013472 0.36 0.0021 0.0763 gbjAI013472 EST208147 Normalized
rat spleen, Bento Soares Rattus sp. cDNA
clone RSPBL95 30 end, mRNA sequence
[AI013472]
A_44_P1038341 Hal NM_017159 0.47 0.0021 0.0765 refjRattus norvegicus histidine
ammonia lyase (Hal), mRNA
[NM_017159]
A_44_P575890 TC602730 TC602730 0.40 0.0021 0.0765 tcjQ7TQ12_RAT (Q7TQ12) Aa1114,
partial (9%) [TC602730]
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A_44_P352912 AI575434 AI575434 0.22 0.0021 0.0765 gbjAI575434 UI-R-Y0-vg-c-11-0-UI.s1
UI-R-Y0 Rattus norvegicus cDNA clone
UI-R-Y0-vg-c-11-0-UI 30 , mRNA
sequence [AI575434]
A_42_P710309 FQ216592 FQ216592 0.23 0.0022 0.0768 gbjRattus norvegicus TL0ACA41YP14
mRNA sequence. [FQ216592]
A_42_P823706 Wdtc1 NM_001107908 0.27 0.0022 0.0768 refjRattus norvegicus WD and
tetratricopeptide repeats 1 (Wdtc1),
mRNA [NM_001107908]
A_44_P503215 AA799326 AA799326 0.57 0.0022 0.0768 gbjAA799326 EST188823 Normalized
rat heart, Bento Soares Rattus sp. cDNA
clone RHEAA33 30 end similar to fatty
acid transport protein, mRNA sequence
[AA799326]
A_44_P1045734 Stac3 NM_001130558 2.94 0.0022 0.0768 refjRattus norvegicus SH3 and cysteine
rich domain 3 (Stac3), mRNA
[NM_001130558]




A_43_P11350 Nt5dc2 NM_001009271 0.26 0.0022 0.0771 refjRattus norvegicus 50-nucleotidase
domain containing 2 (Nt5dc2), mRNA
[NM_001009271]
A_44_P659386 A_44_P659386 A_44_P659386 0.23 0.0022 0.0777 Unknown
A_44_P388545 BM986478 BM986478 0.25 0.0022 0.0777 gbjBM986478 EST594072 Rat gene
index, normalized rat, norvegicus
Rattus norvegicus cDNA clone
RGOAC57 30 end, mRNA sequence
[BM986478]
A_43_P14265 TC608958 TC608958 0.28 0.0022 0.0777 tcjQ2G7V7_NOVAD (Q2G7V7) Glycosyl
transferase, group 1, partial (4%)
[TC608958]
A_44_P921786 AI072054 AI072054 0.18 0.0023 0.0777 gbjAI072054 UI-R-C2-nf-a-03-0-UI.s1
UI-R-C2 Rattus norvegicus cDNA clone
UI-R-C2-nf-a-03-0-UI 30 , mRNA
sequence [AI072054]
A_44_P329944 AA945177 AA945177 0.23 0.0023 0.0777 gbjAA945177 EST200676 Normalized
rat liver, Bento Soares Rattus sp. cDNA
clone RLIAH53 30 end, mRNA sequence
[AA945177]
A_44_P413821 AA956104 AA956104 0.23 0.0023 0.0777 gbjAA956104 UI-R-E1-ﬁ-e-03-0-UI.s1
UI-R-E1 Rattus norvegicus cDNA clone
UI-R-E1-ﬁ-e-03-0-UI 30 similar to gi
[AA956104]
A_44_P484393 Ptma NM_021740 0.29 0.0023 0.0777 refjRattus norvegicus prothymosin
alpha (Ptma), mRNA [NM_021740]
A_44_P163957 XM_343681 XM_343681 0.22 0.0023 0.0777 gbjRattus norvegicus LOC363343
(LOC363343), mRNA [XM_343681]
A_43_P12332 Nolc1 NM_022869 0.26 0.0023 0.0777 refjRattus norvegicus nucleolar and
coiled-body phosphoprotein 1 (Nolc1),
mRNA [NM_022869]
A_44_P257135 Slc29a3 NM_181639 0.28 0.0023 0.0777 refjRattus norvegicus solute carrier
family 29 (nucleoside transporters),
member 3 (Slc29a3), mRNA
[NM_181639]
A_44_P704817 A_44_P704817 A_44_P704817 0.29 0.0023 0.0777 Unknown
A_44_P104221 BQ194442 BQ194442 0.34 0.0023 0.0777 gbjBQ194442 UI-R-CN1-cma-f-24-0-
UI.s1 UI-R-CN1 Rattus norvegicus cDNA
clone UI-R-CN1-cma-f-24-0-UI 30 ,
mRNA sequence [BQ194442]
A_44_P165037 Zfpm1 NM_001242627 0.35 0.0023 0.0777 refjRattus norvegicus zinc ﬁnger
protein, multitype 1 (Zfpm1), mRNA
[NM_001242627]
A_44_P198304 AW527961 AW527961 0.42 0.0023 0.0777 gbjAW527961 UI-R-BT1-akg-b-05-0-
UI.s1 UI-R-BT1 Rattus norvegicus cDNA
clone UI-R-BT1-akg-b-05-0-UI 30 ,
mRNA sequence [AW527961]
A_44_P374638 Hsd17b2 NM_024391 0.49 0.0023 0.0777 refjRattus norvegicus hydroxysteroid
(17-beta) dehydrogenase 2 (Hsd17b2),
mRNA [NM_024391]
A_44_P473223 XM_344209 XM_344209 0.62 0.0023 0.0777 gbjRattus norvegicus similar to RIKEN
cDNA 1700081O22 (LOC364100),
mRNA [XM_344209]
A_44_P487856 Tymp NM_001012122 1.07 0.0023 0.0777 refjRattus norvegicus thymidine
phosphorylase (Tymp), mRNA
[NM_001012122]
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A_44_P750262 TC610217 TC610217 0.27 0.0024 0.0781 Unknown
A_44_P341204 AA997107 AA997107 0.29 0.0024 0.0786 gbjAA997107 UI-R-C0-hr-d-04-0-UI.s1
UI-R-C0 Rattus norvegicus cDNA clone
UI-R-C0-hr-d-04-0-UI 30 , mRNA
sequence [AA997107]
A_44_P361465 Odf3b NM_001191992 0.70 0.0024 0.0786 refjRattus norvegicus outer dense ﬁber
of sperm tails 3B (Odf3b), mRNA
[NM_001191992]
A_44_P496853 A_44_P496853 A_44_P496853 0.31 0.0024 0.0789 Unknown
A_44_P324189 AI235446 AI235446 0.42 0.0024 0.0789 gbjAI235446 EST232008 Normalized
rat ovary, Bento Soares Rattus sp. cDNA
clone ROVCR88 30 end, mRNA sequence
[AI235446]
A_44_P1071170 M16349 M16349 0.44 0.0024 0.0789 gbjRat asialoglycoprotein receptor
RHL1 mRNA, 50 end. [M16349]
A_43_P11857 Avpr1b NM_017205 0.18 0.0024 0.0792 refjRattus norvegicus arginine
vasopressin receptor 1B (Avpr1b),
mRNA [NM_017205]
A_44_P791057 A_44_P791057 A_44_P791057 0.20 0.0025 0.0792 Unknown
A_44_P351452 Bmp1 NM_031323 0.34 0.0025 0.0795 refjRattus norvegicus bone
morphogenetic protein 1 (Bmp1),
mRNA [NM_031323]
A_44_P653879 TC596924 TC596924 0.22 0.0025 0.0797 Unknown
A_44_P1018129 TC610213 TC610213 0.55 0.0025 0.0800 Unknown
A_44_P435381 Agxt NM_030656 0.36 0.0025 0.0800 refjRattus norvegicus alanine-
glyoxylate aminotransferase (Agxt),
mRNA [NM_030656]
A_44_P450258 Fitm2 NM_001107799 0.18 0.0025 0.0802 refjRattus norvegicus fat storage-
inducing transmembrane protein 2
(Fitm2), mRNA [NM_001107799]
A_44_P539597 AA818108 AA818108 0.19 0.0025 0.0802 gbjUI-R-A0-am-f-08-0-UI.s1 UI-R-A0
Rattus norvegicus cDNA clone UI-R-A0-
am-f-08-0-UI 30 similar to gb
[AA818108]
A_42_P570300 Depdc5 NM_001107229 0.23 0.0026 0.0802 refjRattus norvegicus DEP domain
containing 5 (Depdc5), mRNA
[NM_001107229]
A_43_P11285 Apitd1 NM_001204879 0.64 0.0026 0.0804 refjRattus norvegicus apoptosis-
inducing, TAF9-like domain 1 (Apitd1),
mRNA [NM_001204879]
A_42_P589201 Slc15a4 NM_144758 0.19 0.0026 0.0814 refjRattus norvegicus solute carrier
family 15, member 4 (Slc15a4), mRNA
[NM_144758]
A_44_P555638 Prickle3 NM_001014110 0.25 0.0027 0.0814 refjRattus norvegicus prickle homolog 3
(Drosophila) (Prickle3), mRNA
[NM_001014110]
A_42_P647072 Mapkapk2 NM_178102 0.31 0.0027 0.0814 refjRattus norvegicus mitogen-
activated protein kinase-activated
protein kinase 2 (Mapkapk2), mRNA
[NM_178102]
A_43_P17569 Sel1l3 XM_341223 0.52 0.0026 0.0814 refjPREDICTED: Rattus norvegicus
similar to RIKEN cDNA 2310045A20
(RGD1562860), mRNA [XM_341223]
A_43_P15779 Hapln2 NM_022285 0.16 0.0027 0.0815 refjRattus norvegicus hyaluronan and
proteoglycan link protein 2 (Hapln2),
mRNA [NM_022285]
A_44_P209949 BQ211506 BQ211506 0.20 0.0027 0.0827 gbjBQ211506 UI-R-DY1-cnq-h-17-0-
UI.s1 NCI_CGAP_DY1 Rattus norvegicus
cDNA clone IMAGE:7333411 30 , mRNA
sequence [BQ211506]





A_43_P12474 Ap2a2 NM_031008 0.27 0.0027 0.0827 refjRattus norvegicus adaptor-related
protein complex 2, alpha 2 subunit
(Ap2a2), mRNA [NM_031008]
A_44_P384260 Ninj2 NM_021595 0.66 0.0027 0.0827 refjRattus norvegicus ninjurin 2 (Ninj2),
mRNA [NM_021595]
A_44_P164947 AI177413 AI177413 0.35 0.0027 0.0829 gbjAI177413 EST221033 Normalized
rat placenta, Bento Soares Rattus sp.
cDNA clone RPLBY89 30 end, mRNA
sequence [AI177413]
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A_44_P482267 Elovl5 NM_134382 0.28 0.0028 0.0832 refjRattus norvegicus ELOVL family
member 5, elongation of long chain
fatty acids (yeast) (Elovl5), mRNA
[NM_134382]
A_44_P715517 RGD1309228 NM_001017451 0.26 0.0028 0.0834 refjRattus norvegicus similar to
putative protein, with at least 9
transmembrane domains, of eukaryotic
origin (43.9 kDa) (2G415)
(RGD1309228), mRNA
[NM_001017451]
A_44_P423458 AI100773 AI100773 0.23 0.0028 0.0839 gbjAI100773 EST210062 Normalized
rat brain, Bento Soares Rattus sp. cDNA
clone RBRBA09 30 end, mRNA sequence
[AI100773]
A_44_P869863 TC606533 TC606533 0.44 0.0028 0.0839 Unknown
A_44_P840751 TC635476 TC635476 0.18 0.0029 0.0840 Unknown
A_44_P334900 Gdf6 NM_001013038 0.24 0.0029 0.0840 refjRattus norvegicus growth
differentiation factor 6 (Gdf6), mRNA
[NM_001013038]
A_44_P494310 Bri3 NM_001009604 0.30 0.0028 0.0840 refjRattus norvegicus brain protein I3
(Bri3), mRNA [NM_001009604]
A_44_P374375 TC648121 TC648121 0.43 0.0028 0.0840 tcjAPOM_RAT (P14630) Apolipoprotein
M precursor (Apo-M) (ApoM) (Protein
Px), partial (41%) [TC648121]
A_44_P825985 TC625236 TC625236 0.45 0.0028 0.0840 Unknown
A_44_P920467 FQ221509 FQ221509 0.38 0.0029 0.0841 gbjRattus norvegicus TL0ADA35YE20
mRNA sequence. [FQ221509]
A_43_P11951 Ucn NM_019150 0.21 0.0029 0.0851 refjRattus norvegicus urocortin (Ucn),
mRNA [NM_019150]
A_44_P668704 TC585807 TC585807 0.30 0.0029 0.0851 Unknown
A_43_P14751 Aqp9 NM_022960 0.43 0.0029 0.0851 refjRattus norvegicus aquaporin 9
(Aqp9), mRNA [NM_022960]
A_42_P676630 Gpld1 NM_001100512 0.35 0.0029 0.0853 refjRattus norvegicus
glycosylphosphatidylinositol speciﬁc
phospholipase D1 (Gpld1), mRNA
[NM_001100512]
A_44_P1059556 Cyp4a1 NM_175837 0.65 0.0029 0.0853 refjRattus norvegicus cytochrome P450,
family 4, subfamily a, polypeptide 1
(Cyp4a1), mRNA [NM_175837]
A_44_P428166 AW527148 AW527148 0.16 0.0030 0.0853 gbjAW527148 UI-R-BO1-ajm-a-12-0-
UI.s1 UI-R-BO1 Rattus norvegicus cDNA
clone UI-R-BO1-ajm-a-12-0-UI 30 ,
mRNA sequence [AW527148]
A_44_P377520 A_44_P377520 A_44_P377520 0.29 0.0030 0.0853 Unknown
A_44_P996268 Rasd2 NM_133568 0.35 0.0030 0.0853 refjRattus norvegicus RASD family,
member 2 (Rasd2), mRNA
[NM_133568]
A_44_P761492 Perld1 NM_001143895 0.16 0.0030 0.0854 refjRattus norvegicus per1-like domain
containing 1 (Perld1), mRNA
[NM_001143895]




A_44_P1048296 Osbpl1a NM_172023 0.33 0.0031 0.0867 refjRattus norvegicus oxysterol binding
protein-like 1A (Osbpl1a), mRNA
[NM_172023]
A_44_P573155 CA508976 CA508976 0.21 0.0031 0.0875 gbjUI-R-FS0-cqm-n-08-0-UI.s1 UI-R-
FS0 Rattus norvegicus cDNA clone UI-R-
FS0-cqm-n-08-0-UI 30 , mRNA sequence
[CA508976]
A_44_P336753 AC096165 AC096165 0.19 0.0031 0.0876 gbjRattus norvegicus clone CH230-
11H2, *** SEQUENCING IN PROGRESS
***, 45 unordered pieces [AC096165]
A_44_P134672 Snapc3 NM_001013212 0.31 0.0032 0.0884 refjRattus norvegicus small nuclear RNA
activating complex, polypeptide 3
(Snapc3), mRNA [NM_001013212]
A_44_P430033 AI231180 AI231180 0.39 0.0032 0.0884 gbjAI231180 EST227868 Normalized
rat embryo, Bento Soares Rattus sp.
cDNA clone REMDG81 30 end, mRNA
sequence [AI231180]




A_44_P793109 TC601680 TC601680 0.18 0.0032 0.0887 Unknown
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A_43_P12530 Suox NM_031127 0.27 0.0033 0.0889 refjRattus norvegicus sulﬁte oxidase
(Suox), nuclear gene encoding
mitochondrial protein, mRNA
[NM_031127]
A_43_P23361 Aen NM_001108487 0.27 0.0033 0.0889 refjRattus norvegicus apoptosis
enhancing nuclease (Aen), mRNA
[NM_001108487]
A_44_P143896 BQ211430 BQ211430 0.22 0.0033 0.0889 gbjBQ211430 UI-R-DY1-cok-f-02-0-
UI.s1 NCI_CGAP_DY1 Rattus norvegicus
cDNA clone IMAGE:7336420 30 , mRNA
sequence [BQ211430]




A_44_P301367 AA800240 AA800240 0.29 0.0033 0.0889 gbjAA800240 EST189737 Normalized
rat heart, Bento Soares Rattus sp. cDNA
clone RHEAM82 30 end, mRNA sequence
[AA800240]
A_44_P235448 BE110597 BE110597 0.32 0.0033 0.0891 gbjBE110597 UI-R-BJ1-avt-h-02-0-
UI.s1 UI-R-BJ1 Rattus norvegicus cDNA
clone UI-R-BJ1-avt-h-02-0-UI 30 , mRNA
sequence [BE110597]
A_44_P390826 BF282632 BF282632 0.31 0.0033 0.0893 gbjBF282632 EST447223 Rat Gene
Index, normalized rat, Rattus
norvegicus cDNA Rattus norvegicus
cDNA clone RGIDR08 30 sequence,
mRNA sequence [BF282632]
A_44_P654096 TC600000 TC600000 0.32 0.0034 0.0893 Unknown
A_44_P202434 AA819129 AA819129 0.44 0.0033 0.0893 gbjAA819129 UI-R-A0-ba-b-08-0-UI.s1
UI-R-A0 Rattus norvegicus cDNA clone
UI-R-A0-ba-b-08-0-UI 30 similar to emb
[AA819129]
A_44_P809199 TC614636 TC614636 0.46 0.0033 0.0893 Unknown
A_44_P399038 TC624112 TC624112 0.20 0.0034 0.0896 tcjQ6L7M6_9DELA (Q6L7M6) P12,
partial (15%) [TC624112]
A_43_P16962 LOC301128 BC098860 0.24 0.0034 0.0896 gbjRattus norvegicus similar to jumonji
domain containing 2B, mRNA (cDNA
clone IMAGE:7380411), complete cds.
[BC098860]
A_42_P490296 Itgb4 NM_013180 0.24 0.0035 0.0896 refjRattus norvegicus integrin, beta 4
(Itgb4), mRNA [NM_013180]
A_44_P1037493 Tssc4 NM_001013194 0.25 0.0035 0.0896 refjRattus norvegicus tumor
suppressing subtransferable candidate
4 (Tssc4), mRNA [NM_001013194]
A_42_P456939 Slc35b4 NM_001106590 0.26 0.0034 0.0896 refjRattus norvegicus solute carrier
family 35, member B4 (Slc35b4), mRNA
[NM_001106590]
A_44_P1024739 Wipi2 NM_001007615 0.27 0.0034 0.0896 refjRattus norvegicus WD repeat
domain, phosphoinositide interacting 2
(Wipi2), mRNA [NM_001007615]
A_44_P165513 Dfnb31 NM_181088 0.28 0.0035 0.0896 refjRattus norvegicus deafness,
autosomal recessive 31 (Dfnb31),
mRNA [NM_181088]
A_44_P174588 FQ213162 FQ213162 0.35 0.0034 0.0896 gbjRattus norvegicus TL0AAA49YG06
mRNA sequence. [FQ213162]
A_44_P959251 A_44_P959251 A_44_P959251 0.37 0.0035 0.0896 Unknown
A_44_P240156 BI281697 BI281697 0.38 0.0034 0.0896 gbjBI281697 UI-R-CT0s-cav-d-07-0-
UI.s1 UI-R-CT0s Rattus norvegicus
cDNA clone UI-R-CT0s-cav-d-07-0-UI
30 , mRNA sequence [BI281697]
A_44_P491393 Nudt7 NM_001108450 0.43 0.0035 0.0896 refjRattus norvegicus nudix (nucleoside
diphosphate linked moiety X)-type
motif 7 (Nudt7), mRNA
[NM_001108450]
A_44_P291028 Arhgef19 NM_001108692 0.59 0.0034 0.0896 refjRattus norvegicus Rho guanine
nucleotide exchange factor (GEF) 19
(Arhgef19), mRNA [NM_001108692]
A_44_P339202 Ppp1r12c NM_001191946 0.20 0.0035 0.0899 refjRattus norvegicus protein
phosphatase 1, regulatory (inhibitor)
subunit 12C (Ppp1r12c), mRNA
[NM_001191946]
A_42_P483419 Oaz1 NM_139081 0.29 0.0035 0.0901 refjRattus norvegicus ornithine
decarboxylase antizyme 1 (Oaz1),
mRNA [NM_139081]
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A_44_P101960 BF408841 BF408841 0.32 0.0036 0.0909 gbjBF408841 UI-R-BS2-bet-a-09-0-
UI.s1 UI-R-BS2 Rattus norvegicus cDNA
clone UI-R-BS2-bet-a-09-0-UI 30 , mRNA
sequence [BF408841]
A_44_P239864 AI231358 AI231358 0.33 0.0036 0.0909 gbjAI231358 EST228046 Normalized
rat embryo, Bento Soares Rattus sp.
cDNA clone REMDJ10 30 end, mRNA
sequence [AI231358]
A_44_P977792 CF111812 CF111812 0.32 0.0036 0.0910 gbjShultzomica05063 Rat lung airway
and parenchyma cDNA libraries Rattus
norvegicus cDNA clone Contig963 50 ,
mRNA sequence [CF111812]
A_44_P149572 Rassf7 NM_001106317 0.28 0.0036 0.0911 refjRattus norvegicus Ras association
(RalGDS/AF-6) domain family (N-
terminal) member 7 (Rassf7), mRNA
[NM_001106317]




A_44_P280376 AI009427 AI009427 0.37 0.0037 0.0919 gbjAI009427 EST203878 Normalized
rat heart, Bento Soares Rattus sp. cDNA
clone RHEBJ81 30 end, mRNA sequence
[AI009427]
A_44_P971681 AI169156 AI169156 0.31 0.0037 0.0928 gbjAI169156 EST214990 Normalized
rat kidney, Bento Soares Rattus sp.
cDNA clone RKIBO21 30 end, mRNA
sequence [AI169156]
A_44_P134993 Agxt NM_030656 0.35 0.0037 0.0928 refjRattus norvegicus alanine-
glyoxylate aminotransferase (Agxt),
mRNA [NM_030656]
A_42_P470649 Dio1 NM_021653 0.38 0.0037 0.0928 refjRattus norvegicus deiodinase,
iodothyronine, type I (Dio1), mRNA
[NM_021653]
A_44_P517033 LOC312502 XR_085818 0.39 0.0037 0.0928 refjPREDICTED: Rattus norvegicus
similar to RAB11 family interacting
protein 5 (class I) isoform 1
(LOC312502), miscRNA [XR_085818]
A_44_P333071 Lrp1 NM_001130490 0.46 0.0037 0.0928 refjRattus norvegicus low density
lipoprotein receptor-related protein 1
(Lrp1), mRNA [NM_001130490]
A_43_P21931 Ncapd3 NM_001034000 0.16 0.0038 0.0931 refjRattus norvegicus non-SMC
condensin II complex, subunit D3
(Ncapd3), mRNA [NM_001034000]
A_44_P191862 Hras NM_001098241 0.26 0.0038 0.0931 refjRattus norvegicus Harvey rat
sarcoma virus oncogene (Hras),
transcript variant 2, mRNA
[NM_001098241]




A_44_P179114 AA943131 AA943131 0.28 0.0038 0.0931 gbjAA943131 EST198630 Normalized
rat brain, Bento Soares Rattus sp. cDNA
clone RBRAF44 30 end, mRNA sequence
[AA943131]
A_44_P394332 FQ239759 FQ239759 0.34 0.0038 0.0931 gbjFQ239759 Rattus norvegicus liver
Sprague–Dawley Rattus norvegicus
cDNA clone TL0ABA6YL07 30 , mRNA
sequence [FQ239759]




A_43_P18016 TC608166 TC608166 0.48 0.0038 0.0931 tcjQ91ZX7_MOUSE (Q91ZX7)
Lipoprotein receptor-related protein,
partial (4%) [TC608166]
A_44_P375616 Slc16a11 NM_001105797 1.02 0.0038 0.0931 refjRattus norvegicus solute carrier
family 16 (monocarboxylic acid
transporters), member 11 (Slc16a11),
mRNA [NM_001105797]
A_44_P244839 BF397813 BF397813 0.29 0.0039 0.0931 gbjBF397813 UI-R-BS2-bee-h-09-0-
UI.s1 UI-R-BS2 Rattus norvegicus cDNA
clone UI-R-BS2-bee-h-09-0-UI 30 ,
mRNA sequence [BF397813]
A_44_P915992 TC601232 TC601232 0.33 0.0039 0.0931 Unknown
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ProbeName GeneName SystematicName log 2 (FIP/CTRL) p-value q-value Description
A_43_P13801 TC607835 TC607835 0.18 0.0039 0.0932 tcjP70602_RAT (P70602) Protein
tyrosine phosphatase 20, partial (9%)
[TC607835]
A_44_P209911 Nolc1 NM_022869 0.24 0.0039 0.0932 refjRattus norvegicus nucleolar and
coiled-body phosphoprotein 1 (Nolc1),
mRNA [NM_022869]
A_44_P254201 BF398403 BF398403 0.24 0.0039 0.0933 gbjBF398403 UI-R-BS2-beo-d-10-0-
UI.s1 UI-R-BS2 Rattus norvegicus cDNA
clone UI-R-BS2-beo-d-10-0-UI 30 ,
mRNA sequence [BF398403]
A_44_P273639 BF414043 BF414043 0.27 0.0039 0.0935 gbjBF414043 UI-R-BJ2-bol-g-02-0-
UI.s1 UI-R-BJ2 Rattus norvegicus cDNA
clone UI-R-BJ2-bol-g-02-0-UI 30 , mRNA
sequence [BF414043]
A_44_P523401 AI234078 AI234078 0.26 0.0040 0.0941 gbjEST230766 Normalized rat lung,
Bento Soares Rattus sp. cDNA clone
RLUCU81 30 end, mRNA sequence
[AI234078]
A_44_P258855 Qsox1 NM_053431 0.38 0.0040 0.0941 refjRattus norvegicus quiescin Q6
sulfhydryl oxidase 1 (Qsox1), transcript
variant 2, mRNA [NM_053431]
A_44_P347253 Zc3h12a NM_001077671 0.17 0.0040 0.0945 refjRattus norvegicus zinc ﬁnger CCCH
type containing 12A (Zc3h12a), mRNA
[NM_001077671]
A_42_P775698 Prmt1 NM_024363 0.19 0.0040 0.0945 refjRattus norvegicus protein arginine
methyltransferase 1 (Prmt1), mRNA
[NM_024363]
A_44_P126597 Paqr4 NM_001017377 0.25 0.0040 0.0945 refjRattus norvegicus progestin and
adipoQ receptor family member IV
(Paqr4), mRNA [NM_001017377]
A_44_P125399 AI172437 AI172437 0.30 0.0040 0.0945 gbjAI172437 EST218445 Normalized
rat muscle, Bento Soares Rattus sp.
cDNA clone RMUBZ59 30 end, mRNA
sequence [AI172437]
A_44_P376545 AI136203 AI136203 0.32 0.0040 0.0945 gbjAI136203 UI-R-C2p-ns-f-05-0-UI.s1
UI-R-C2p Rattus norvegicus cDNA clone
UI-R-C2p-ns-f-05-0-UI 30 , mRNA
sequence [AI136203]
A_44_P502696 AA875523 AA875523 0.37 0.0040 0.0945 gbjAA875523 UI-R-E0-cv-e-11-0-UI.s1
UI-R-E0 Rattus norvegicus cDNA clone
UI-R-E0-cv-e-11-0-UI 30 similar to gi
[AA875523]
A_44_P819950 AA924747 AA924747 0.30 0.0041 0.0950 gbjAA924747 UI-R-A1-ed-h-01-0-UI.s1
UI-R-A1 Rattus norvegicus cDNA clone
UI-R-A1-ed-h-01-0-UI 30 similar to gi
[AA924747]
A_42_P673212 Cad NM_001105710 0.24 0.0041 0.0954 refjRattus norvegicus carbamoyl-
phosphate synthetase 2, aspartate
transcarbamylase, and dihydroorotase
(Cad), mRNA [NM_001105710]
A_44_P105889 BF401054 BF401054 0.18 0.0041 0.0956 gbjBF401054 UI-R-CA0-bgh-b-01-0-
UI.s1 UI-R-CA0 Rattus norvegicus cDNA
clone UI-R-CA0-bgh-b-01-0-UI 30 ,
mRNA sequence [BF401054]
A_44_P714729 TC590838 TC590838 0.31 0.0041 0.0956 tcjQ7TQ12_RAT (Q7TQ12) Aa1114,
partial (9%) [TC590838]
A_44_P461932 XM_228533 XM_228533 0.58 0.0041 0.0956 gbjRattus norvegicus similar to 40S
ribosomal protein S8 (LOC302393),
mRNA [XM_228533]
A_44_P423435 BF283419 BF283419 0.18 0.0042 0.0960 gbjBF283419 EST448010 Rat Gene
Index, normalized rat, Rattus
norvegicus cDNA Rattus norvegicus
cDNA clone RGIEB77 30 sequence,
mRNA sequence [BF283419]




A_44_P232319 TC595327 TC595327 0.27 0.0042 0.0961 tcjHSU37689 RNA polymerase II
subunit {Homo sapiens} (exp=-1;
wgp=0; cg=0), partial (19%) [TC595327]
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ProbeName GeneName SystematicName log 2 (FIP/CTRL) p-value q-value Description
A_42_P643349 Myl4 NM_001109495 0.21 0.0042 0.0966 refjRattus norvegicus myosin, light
chain 4 (Myl4), mRNA
[NM_001109495]
A_44_P521946 FQ235081 FQ235081 0.23 0.0042 0.0966 gbjRattus norvegicus TL0AEA56YI18
mRNA sequence. [FQ235081]
A_44_P902085 FQ217643 FQ217643 0.24 0.0042 0.0966 gbjRattus norvegicus TL0ACA21YB15
mRNA sequence. [FQ217643]
A_44_P1053032 Rnf150 NM_001191093 0.26 0.0042 0.0966 refjRattus norvegicus ring ﬁnger protein
150 (Rnf150), mRNA [NM_001191093]
A_44_P409709 Phldb1 NM_001191578 0.20 0.0043 0.0972 refjRattus norvegicus pleckstrin
homology-like domain, family B,
member 1 (Phldb1), mRNA
[NM_001191578]
A_44_P351032 AA944168 AA944168 0.18 0.0043 0.0986 gbjAA944168 EST199667 Normalized
rat embryo, Bento Soares Rattus sp.
cDNA clone REMAD20 30 end, mRNA
sequence [AA944168]
A_44_P1025476 Krt18 NM_053976 0.33 0.0044 0.0992 refjRattus norvegicus keratin 18
(Krt18), mRNA [NM_053976]
A_44_P524583 AI232320 AI232320 0.42 0.0044 0.0993 gbjAI232320 EST229008 Normalized
rat kidney, Bento Soares Rattus sp.
cDNA clone RKICA20 30 end similar to
similar to mitochondrial 3-hydroxy-3-
methylglutaryl-CoA synthase, mRNA
sequence [AI232320]
A_42_P654862 Fam189b NM_001107690 0.25 0.0044 0.0998 refjRattus norvegicus family with
sequence similarity 189, member B
(Fam189b), mRNA [NM_001107690]
A_44_P262102 Pafah1b3 NM_053654 0.32 0.0044 0.0998 refjRattus norvegicus platelet-
activating factor acetylhydrolase,
isoform 1b, subunit 3 (Pafah1b3), mRNA
[NM_053654]
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genes (Fig. 2A and Table 5). Because these latter effects were only
partially conﬁrmed by qPCR and were poorly reproduced in
ﬁpronil-treated mice (Fig. 3), our subsequent investigations were
mainly focused on genes with upregulated expression after
ﬁpronil treatment.
Our microarray results and a previous report showing that
ﬁpronil could activate, although relatively weakly, human PXR
[13] led us to hypothesize that the nuclear receptors CAR and
PXR, two major regulators of hepatic biotransformation systems,
could mediate a substantial part of the effects of ﬁpronil on liver
gene expression. An analysis of our microarray data through the
use of IPA (Ingenuity Systems, www.ingenuity.com) also
suggested that CAR and PXR were the major upstream regulators
of liver gene expression upon ﬁpronil treatment (data not
shown). We ﬁrst evaluated this hypothesis by comparing our
gene expression proﬁles to those obtained by Ren et al. [19, GEO
record GSE14712] in female rats exposed to phenobarbital (CAR
and PXR activator) or PCN (PXR activator). Despite a limited
overlap between the contents screened by Affymetrix and
Agilent rat microarrays, we could show that approximately half
of the genes regulated by ﬁpronil in rat liver were also regulated
by PB and/or PCN (Fig. 2B). Finally, we conﬁrmed by qPCR the
upregulation by ﬁpronil of several genes involved in the
metabolism and transport of xenobiotics and endogenous
compounds (Fig. 2C–E).
3.2. Comparable but reduced effects of ﬁpronil on mouse liver gene
expression
In order to evaluate in vivo the role of CAR and/or PXR on
liver gene expression regulations induced by ﬁpronil, we chose to
use nuclear receptor-deﬁcient mice. As a preliminary study, we
evaluated the impact of ﬁpronil treatment (5 mg/kg per day, 14
days) on liver gene expression in wild-type C57BL/6J male mice.Fipronil treatment resulted in an 8% increase in liver weight
(1.10  0.03 g vs 1.18  0.02 g for control and ﬁpronil-treated groups
respectively, p = 0.047) as well as a 5% decrease in mean body weight
at the end of the experiment (24.4  0.3 g vs 23.2  0.3 g respectively,
p < 0.05) linked to a reduced body weight gain during the study in the
group treated with ﬁpronil (4.4% vs 0.7% increase in body weight
respectively, p < 0.05).
We assayed by qPCR the hepatic expression of several mouse
orthologs of the genes that were found to be upregulated in rats
following ﬁpronil treatment. As shown in Fig. 4, ﬁpronil treatment
in mouse also led to the upregulation of genes involved in the
different phases of xenobiotic metabolism. Among phase I hepatic
enzymes, we found that the prototypical CAR/PXR target genes
Cyp2b10 and Cyp3a11 together with the gene encoding carbox-
ylesterase Ces2a (mouse ortholog of rat Ces6) were strongly
induced following ﬁpronil treatment (Fig. 4A). The expression of
the phase II enzymes Ugt1a1 and Sult1b1 which are involved in the
conjugation of thyroid hormones [20,21] were signiﬁcantly
increased upon ﬁpronil treatment (Fig. 4B) but to a lower extent
than their orthologs in rat liver (Fig. 2D). On the contrary, the
expression of Gsta2 was increased as robustly in mouse as in rat
(Fig. 4B). Among the membrane transporters tested, the strongest
increases in expression were observed for Abcc3 and the thyroid
hormone transporter Slco1a4 (Fig. 4C). Interestingly, the expres-
sion of the sterol transporters Abcg5 and Abcg8 (Fig. 4C) was also
increased by ﬁpronil treatment in mouse liver although to a much
lower extent than in rat (Fig. 2E). The expression of other genes
involved in the metabolism of xenobiotics and endogenous
compounds that we assayed by qPCR showed no or very limited
changes (Fig. 5). Thus, overall, the effects of ﬁpronil on hepatic
gene expression related to biotransformation systems and
membrane transporters were reproduced to a large extent in
mouse but several modulations were of very limited amplitude in
this model, including genes involved in thyroid hormone
metabolism.
Fig. 2. Effects of ﬁpronil on the rat hepatic transcriptome. (A) Gene expression proﬁles were obtained by microarray analysis (Agilent 4x44K whole rat genome) of liver
samples from rats treated with ﬁpronil (3 mg/kg per day, 14 days, n = 8) or the vehicle alone (n = 7). The heatmap represents the data obtained on all samples for the 712
differentially expressed probes (402 up- and 310 downregulated, q-value < 0.1). Hierarchical clustering was applied to the samples and the probes using 1-Pearson
correlation coefﬁcient as distance and the Ward’s criterion for agglomeration. The top three GO biological processes most signiﬁcantly enriched among the upregulated or
downregulated genes are indicated. (B) Raw microarray data for female rats exposed to the PXR activator pregnenolone-16alpha-carbonitrile (PCN), to the CAR and PXR
activator phenobarbital (PB) or to the vehicle alone for 6 h, 24 h or 5 days were obtained from GEO [GSE14712, [19]]. Data were normalized using robust multi-array analysis
(rma) and genes differentially expressed between PB or PCN and the control group at any time point were identiﬁed using limma. For the 3045 genes studied by both the
Agilent and Affymetrix microarrays, the venn diagram illustrates the overlaps between the genes signiﬁcantly up- (red) or downregulated (green) in the liver following
ﬁpronil (our study), PCN or PB exposure (study by Ren et al.). (C, D and E) mRNA expression of genes involved in hepatic xenobiotic metabolism, in particular phase I enzymes
B.B. Roques et al. / Biochemical Pharmacology 86 (2013) 997–10391032
Table 4
GO biological processes enriched in upregulated genes.
GOBPID Pvalue OddsRatio ExpCount Count Size Term
GO:0019748 1.63E08 10.86 1.50 12 51 Secondary metabolic process
GO:0009410 1.10E07 14.90 0.88 9 30 Response to xenobiotic stimulus
GO:0006805 6.44E07 14.56 0.79 8 27 Xenobiotic metabolic process
GO:0055114 1.76E05 2.58 14.02 31 478 Oxidation-reduction process
GO:0015721 1.31E04 22.56 0.29 4 10 Bile acid and bile salt transport
GO:0042493 2.05E04 2.65 8.95 21 305 Response to drug
GO:0019439 2.85E04 10.62 0.62 5 21 Aromatic compound catabolic process
GO:0009812 4.65E04 33.65 0.18 3 6 Flavonoid metabolic process
GO:0017144 7.58E04 12.29 0.44 4 15 Drug metabolic process
GO:0010949 8.56E04 Inf 0.06 2 2 Negative regulation of intestinal phytosterol absorption
GO:0045796 8.56E04 Inf 0.06 2 2 Negative regulation of intestinal cholesterol absorption
GO:0070980 8.56E04 Inf 0.06 2 2 Biphenyl catabolic process
GO:0009056 1.25E03 1.85 23.29 38 794 Catabolic process
GO:0042398 1.59E03 9.65 0.53 4 18 Cellular modiﬁed amino acid biosynthetic process
GO:0006720 1.84E03 5.24 1.32 6 45 Isoprenoid metabolic process
GO:0006749 1.88E03 6.52 0.91 5 31 Glutathione metabolic process
GO:0010033 2.29E03 1.76 25.73 40 877 Response to organic substance
GO:0009822 2.52E03 66.94 0.09 2 3 Alkaloid catabolic process
GO:0046101 2.52E03 66.94 0.09 2 3 Hypoxanthine biosynthetic process
GO:0070233 2.52E03 66.94 0.09 2 3 Negative regulation of T cell apoptosis
GO:0007052 2.56E03 14.41 0.29 3 10 Mitotic spindle organization
GO:0009163 2.56E03 14.41 0.29 3 10 Nucleoside biosynthetic process
GO:0042572 2.56E03 14.41 0.29 3 10 Retinol metabolic process
GO:0046129 2.56E03 14.41 0.29 3 10 Purine ribonucleoside biosynthetic process
GO:0042537 2.58E03 4.86 1.41 6 48 Benzene-containing compound metabolic process
GO:0006855 3.44E03 12.61 0.32 3 11 Drug transmembrane transport
GO:0050892 3.44E03 12.61 0.32 3 11 Intestinal absorption
GO:0016101 3.46E03 7.50 0.65 4 22 Diterpenoid metabolic process
GO:0043436 3.70E03 1.96 13.47 24 459 Oxoacid metabolic process
GO:0044281 4.50E03 1.63 31.86 46 1086 Small molecule metabolic process
GO:0008202 4.61E03 2.71 4.43 11 151 Steroid metabolic process
GO:0006287 4.94E03 33.46 0.12 2 4 Base-excision repair, gap-ﬁlling
GO:0009804 4.94E03 33.46 0.12 2 4 Coumarin metabolic process
GO:0043101 4.94E03 33.46 0.12 2 4 Purine-containing compound salvage
GO:0060045 4.94E03 33.46 0.12 2 4 Positive regulation of cardiac muscle cell proliferation
GO:2000107 4.94E03 33.46 0.12 2 4 Negative regulation of leukocyte apoptosis
GO:0006520 5.43E03 2.42 5.84 13 199 Cellular amino acid metabolic process
GO:0050728 5.59E03 6.43 0.73 4 25 Negative regulation of inﬂammatory response
GO:0030890 5.71E03 10.08 0.38 3 13 Positive regulation of B cell proliferation
GO:0070988 5.71E03 10.08 0.38 3 13 Demethylation
GO:0009719 5.91E03 1.83 15.55 26 530 Response to endogenous stimulus
GO:0048589 6.39E03 2.91 3.37 9 115 Developmental growth
GO:0046686 6.45E03 6.13 0.76 4 26 Response to cadmium ion
GO:0002920 7.12E03 9.17 0.41 3 14 Regulation of humoral immune response
GO:0050777 7.41E03 5.87 0.79 4 27 Negative regulation of immune response
GO:0046700 7.51E03 2.32 6.07 13 207 Heterocycle catabolic process
GO:0031100 7.88E03 3.77 1.76 6 60 Organ regeneration
GO:0045454 8.01E03 4.45 1.26 5 43 Cell redox homeostasis
GO:0010561 8.07E03 22.30 0.15 2 5 Negative regulation of glycoprotein biosynthetic process
GO:0016098 8.07E03 22.30 0.15 2 5 Monoterpenoid metabolic process
GO:0042474 8.07E03 22.30 0.15 2 5 Middle ear morphogenesis
GO:0045916 8.07E03 22.30 0.15 2 5 Negative regulation of complement activation
GO:0070327 8.07E03 22.30 0.15 2 5 Thyroid hormone transport
GO:0009308 8.81E03 2.07 8.33 16 284 Amine metabolic process
GO:0015711 9.70E03 4.23 1.32 5 45 Organic anion transport
The enrichment of GO biological processes was evaluated with a conditional hypergeometric test as implemented in the GOstats R package. GOBPID: gene ontology (GO)
biological process (BP) identiﬁer, Pvalue: p-value of the enrichment test, OddsRatio: odds ratio for the category tested, ExpCount: expected number of genes from the category
in the selected genes, Count: observed number of genes from the category in the selected genes, Size: number of genes annotated with the category in the gene universe,
Term: GO term.
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deﬁcient mice
Based on these observations, we studied the expression of a
selection of robustly regulated genes in wild-type, CAR and PXR-
deﬁcient mice treated with ﬁpronil (3 mg/kg per day, 14 days) or
vehicle (Fig. 6A). The increased expression of Cyp2b10 and Gsta2(C), phase II enzymes (D) and phase III transporters (E) was assayed by RT-qPCR in liver sa
n = 10 including the eight rats used in the microarray study) or the vehicle alone (white b
cassette transporter, Ces: carboxylesterase, Cyp: cytochrome P450, Gst: glutathione S-tr
UDP-glucuronosyltransferase. Signiﬁcantly different from the vehicle group: **p < 0.01mRNAs upon ﬁpronil treatment was not reproduced in this
experiment (Fig. 6A), which could result from the use of older
animals (15–22 week-old) in this study. However, an independent
experiment using higher ﬁpronil doses (10 mg/kg per day, 14 days)
in younger mice (9 week-old) conﬁrmed these modulations in
wild-type mice (Fig. 6B). The induction of Cyp2b10 mRNA
expression by ﬁpronil was completely absent in CAR/ but notmples from female rats treated with ﬁpronil (black bars, 3 mg/kg per day for 14 days,
ars, n = 14 including the seven rats used in the microarray study). Abc: ATP-binding
ansferase, Slco: solute carrier organic anion transporter, Sult: sulfotransferase, Ugt:
.
Table 5
GO biological processes enriched in downregulated genes.
GOBPID Pvalue OddsRatio ExpCount Count Size Term
GO:0048252 2.49E05 162.22 0.07 3 4 Lauric acid metabolic process
GO:0006629 2.17E04 2.63 9.79 22 525 Lipid metabolic process
GO:0046951 1.02E03 107.15 0.06 2 3 Ketone body biosynthetic process
GO:0043277 1.23E03 18.00 0.22 3 12 Apoptotic cell clearance
GO:0010934 2.02E03 53.56 0.07 2 4 Macrophage cytokine production
GO:0019369 2.96E03 12.45 0.30 3 16 Arachidonic acid metabolic process
GO:0043651 3.32E03 35.70 0.09 2 5 Linoleic acid metabolic process
GO:0071702 8.32E03 2.49 4.81 11 258 Organic substance transport
GO:0010884 8.97E03 17.84 0.15 2 8 Positive regulation of lipid storage
GO:0042756 8.97E03 17.84 0.15 2 8 Drinking behavior
The enrichment of GO biological processes was evaluated as in Table 4.
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upon treatment with high ﬁpronil dose was not observed in CAR/
 and PXR/ mice (Fig. 6B). The induction by ﬁpronil of mRNA
expression for Cyp3a11, as well as for Ces2a, Abcc3 and Slco1a4 wasFig. 3. Effect of ﬁpronil on mRNA expression of genes involved in lipid metabolism
in rat and mouse liver. mRNA expression of genes involved in lipid metabolism was
assayed by RT-qPCR in liver samples obtained from rats (A) or mice (B) treated with
ﬁpronil (black bars, 3 mg/kg per day for rat and 5 mg/kg per day for mouse, 14 days,
n = 10 rats including the eight rats used in the microarray study and n = 8 mice
respectively) or the vehicle alone (white bars, n = 14 rats including the seven rats
used in the microarray study and n = 8 mice respectively). Signiﬁcantly different
from the vehicle group: **p < 0.01.completely absent in PXR/ mice (Fig. 6A and B). In CAR/
mice, these regulations were blunted at the moderate ﬁpronil dose
(3 mg/kg per day, Fig. 6A) but were globally maintained at the high
ﬁpronil dose (10 mg/kg per day, Fig. 6B). Thus, overall, the
expression of PXR and to a lesser extent of CAR is required for a full
induction by ﬁpronil of the hepatic expression of genes involved in
xenobiotic and TH metabolism and transport.
3.4. Effects of ﬁpronil on TH clearance and ﬁpronil metabolism in CAR
and PXR-deﬁcient mice
Next, we evaluated whether gene expression modulations
induced by ﬁpronil and their disruption in CAR/ and PXR/
mice were associated with functional consequences on the
metabolism of ﬁpronil itself and on its ability to modulate thyroid
hormone clearance. The oral treatment with ﬁpronil resulted in a
predominant internal exposure to ﬁpronil sulfone in all genotypes
(Fig. 7A). Plasma ﬁpronil sulfone concentrations reached levels
within the same order of magnitude in all three genotypes
(2621  429, 1991  445 and 1985  644 ng/mL for the wild-type,
CAR/ and PXR/ mice, respectively) but were signiﬁcantly lower
in CAR/ and PXR/ mice compared to wild-type mice (Fig. 7A).
Next, we determined the disposition time course of the thyroxine
stable isotope 13C6-LT4 in wild-type, CAR/ and PXR/ mice over a
24 h period following an ip bolus of 13C6-LT4 (Fig. 7B). For wild-type
mice, ﬁpronil treatment was associated to a very limited increase of
the 13C6-LT4 apparent clearance. Similarly, for CAR/ mice a small
increase in the 13C6-LT4 apparent clearance was observed. Moreover,
these mice exhibited a constitutively lower clearance than wild-type
mice. For PXR/ mice, the 13C6-LT4 apparent clearance was not
affected at all by the treatment.
4. Discussion
Fipronil has been described as a thyroid disruptor in rat [3–5].
Treatment of rats with this widely used insecticide reduces plasma
T4 via increased T4 clearance and increases plasma TSH levels
(Fig. 1 and Ref. [4]). These effects on T4 clearance were reproduced
when rats were treated with ﬁpronil sulfone [5], the main ﬁpronil
metabolite which is produced by cytochrome P450-mediated
biotransformation in the liver [7,16]. It is thought that the
induction of liver enzymes involved in the metabolism of thyroid
hormones underlie the thyroid disrupting effects of ﬁpronil [5,22].
Due to the central role of the liver in both ﬁpronil [7,16] and
thyroid hormone metabolism [17,18], we ﬁrst evaluated the
impact of ﬁpronil treatment on the hepatic transcriptome in the
rat. In accordance with previous observations in rat liver [5] and
human hepatocytes [16] we found that ﬁpronil induces the
expression of hepatic phase I detoxiﬁcation enzymes, in particular
Cyp2b1, Cyp2b2 and Cyp3a1 which are involved in ﬁpronil
Fig. 4. Effect of ﬁpronil on mRNA expression of orthologous genes in mouse liver. The mRNA expression of a selection of genes involved in hepatic xenobiotic metabolism, in
particular phase I enzymes (A), phase II enzymes (B) and phase III transporters (C) was assayed by RT-qPCR in liver samples from male C57BL/6J mice treated with ﬁpronil
(black bars, 5 mg/kg per day for 14 days, n = 8) or the vehicle alone (white bars, n = 8). The selection included the mouse orthologs of the genes studied by RT-qPCR in rat liver
(Fig. 2). Signiﬁcantly different from the vehicle group: *p < 0.05, **p < 0.01.
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mRNA expression of the phase II conjugation enzymes Ugt1a1 and
Sult1b1 [5], identiﬁed as key enzymes involved in T4 conjugation in
the liver of female rats [20,21]. Furthermore, we report the
induction by ﬁpronil of hepatic transporters including Abcc2 and
Abcc3 encoding the Multidrug Resistance-associated Proteins
(MRP) MRP2 and MRP3, respectively as well as Slco1a1 and
Slco1a4 encoding the organic anion-transporting polypeptides
(OATP) OATP1 and OATP2, respectively (Fig. 2 and Table 2). Thus,
our study further suggests that the induction of thyroid hormone
transporters involved in both the inﬂux of thyroid hormones into
hepatocytes [OATP1 and OATP2, [23]] and the efﬂux of glucuronide
conjugates of thyroid hormones [MRP2, [24]] may also contribute
to increase hepatic thyroid hormone metabolism following ﬁpronil
treatment. Because MRPs and OATPs have a broad range of
substrates, the impacts of these regulations may extend beyond
the speciﬁc metabolism of thyroid hormones.
The analysis of the effect of ﬁpronil on the hepatic transcrip-
tome and its comparison with the effects of prototypical activators
of the nuclear receptors CAR and/or PXR [19] strongly suggested
that these two xenosensors mediated the effects of ﬁpronil on liver
gene expression. Consistently, ﬁpronil was shown to activate
human PXR in vitro [13]. CAR and PXR are closely related
transcriptional regulators that share target genes, DNA response
elements and activators [25]. They act in concert as major
regulators of hepatic xenobiotic metabolism. Additionally, they
play key roles in regulating the clearance of toxic byproducts of
endogenous metabolism and can also interfere with the metabo-
lism of endogenous hormones [25]. In wild-type but not inCAR-deﬁcient mice, the strong mouse CAR activators TCPOBOP and
phenobarbital are able to reduce T4 but not T3 levels, increase
plasma TSH and induce the hepatic expression of genes involved in
TH metabolism [10,26]. Furthermore, CAR was shown to play a role
in the physiological reduction of TH levels during fasting [10]. The
role of PXR in regulating thyroid hormone metabolism has been
less precisely described. However, using PXR-deﬁcient mice, it was
shown that PXR is necessary for the induction by pregnenolone-16
alpha-carbonitrile (PCN) of hepatic UDP-glucuronosyltransferase
activities toward T3 and T4 [27]. Additionally, the role of PXR in
regulating hepatic TH metabolism can be easily inferred from the
well described thyroid disrupting effects of its numerous
xenobiotic activators [28]. Thus, both receptors mediate the
effects of several xenobiotics on TH homeostasis.
To investigate the respective roles of these transcriptional
regulators in mediating the effect of ﬁpronil on hepatic gene
expression, we used CAR- and PXR-deﬁcient mice. Overall, we
observed that the panel of genes modulated by ﬁpronil was highly
similar between rats and mice, although several responses were
attenuated in mice compared to rats. We selected a set of genes on
which ﬁpronil had a similar impact in both species and evaluated
their regulations in wild-type, CAR-deﬁcient and PXR-deﬁcient
mice. Because CAR and PXR deﬁciencies had a functional impact on
the internal exposure to ﬁpronil sulfone (Fig. 7A) which could
indirectly alter the gene expression modulations, we evaluated the
effects at two different doses: 3 and 10 mg/kg per day. One notable
difference between rats and mice was the absence of induction of
Cyp2b10 mRNA in mice at 3 mg/kg per day (Fig. 6A). While the use
of older mice in this experiment may have played a role, gender
Fig. 5. Effect of ﬁpronil on mRNA expression of genes involved in the metabolism or transport of xenobiotics and endogenous compounds in mouse liver. The mRNA
expression of genes involved in the metabolism (phase I and II) and transport (phase III) of xenobiotics and endogenous compounds, including thyroid hormones (A) and the
mRNA expression of the deiodinases Dio1 and Dio3 (B) were assayed by RT-qPCR in liver samples from mice treated with ﬁpronil (black bars, 5 mg/kg per day for 14 days,
n = 8) or the vehicle alone (white bars, n = 8). Signiﬁcantly different from the vehicle group: *p < 0.05, **p < 0.01.
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and male mice were used in our studies. Endogenous estrogens can
activate both rodent and human CAR [29,30] but only at high
concentrations, reached during pregnancy or pharmacological
treatment. However, it is conceivable that an inhibition of CAR by
testosterone in male mice [29] and/or a synergistic activation of
Cyp2b mRNA expression by ﬁpronil and estradiol in female rats [as
in Ref. [30]] could have contributed to the observed differences
between female rats and male mice for the regulation of Cyp2b
mRNA at 3 mg of ﬁpronil/kg per day. Nevertheless, the induction
by ﬁpronil of Cyp2b10 mRNA, together with other genes involved in
hepatic metabolism, was observed in two independent studies
using younger animals and higher ﬁpronil doses (5 and 10 mg/kg
per day, Figs. 4 and 6B). Taken together, our results show that the
gene expression regulations induced by ﬁpronil are generally
abolished in PXR-deﬁcient mice and are in most of the cases only
reduced in CAR-deﬁcient animals. Thus PXR, and to a lesser extent
CAR, are both involved in mediating the effect of ﬁpronil on liver
gene expression.
However, the activation of CAR and PXR by ﬁpronil in mouse
liver was not associated with a marked increase in thyroid
hormone clearance (Fig. 7B), contrary to the observation made
previously in rats [4]. In rats, the induction of phase II enzymessuch as UDP-glucuronosyltransferases is thought to largely
contribute to the increase in thyroid hormone clearance upon
ﬁpronil treatment [5,20]. Of importance, we observed that ﬁpronil
treatment had a reduced effect in mouse compared to rat on the
expression of phase II enzymes, including Ugts (Table 2, Figs. 2, 4
and 5). Other liver enzyme inducers activating CAR and PXR were
previously shown to have a reduced effect on T4- and bilirubin-
UDP-glucuronosyltransferase activities in mouse compared to rat
[31]. Thus, a differential regulation of phase II glucuronidation
enzymes may well contribute to the different sensitivities of mice
and rats to the induction of thyroid hormone clearance by liver
enzyme inducers, including ﬁpronil. On the other hand, it has been
shown that thyroid disruption by PXR activators does not fully
rely on TH glucuronidation [32]. Thus, differences between rats
and mice in the regulation of genes other than Ugts may also
contribute to the lack of ﬁpronil effect on TH clearance in mice, as
reported in our study. Overall, while CAR and PXR activation by
ﬁpronil is not associated with increased thyroid hormone
clearance in mouse, it is still unclear whether the activation of
these nuclear receptors in rat have functional consequences on
thyroid hormone metabolism and elimination. The development
of PXR- and CAR-deﬁcient rats could represent valuable models to
evaluate such a link.
Fig. 6. Effect of ﬁpronil on liver mRNA expression of a selection of genes in wild-type, CAR/ and PXR/ mice. The mRNA expression of Cyp2b10, Cyp3a11, Ces2a, Gsta2, Abcc3
and Slco1a4 was assayed by RT-qPCR in liver samples from wild-type C57BL/6J (WT), CAR/ and PXR/ male mice treated with ﬁpronil (black bars) or the vehicle alone (white
bars). Fifteen to 22-week-old mice (A) or 9-week-old mice (B) were treated for 14 days with 3 mg/kg per day (A) or 10 mg/kg per day (B) of ﬁpronil or the vehicle alone (n = 5 mice/
group for panel A and n = 8 mice/group for panel B). Signiﬁcantly different from the vehicle group: a, p < 0.05. Signiﬁcantly different from wild-type mice: b, p < 0.05.
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and PXR are the major transcription factors involved in modulating
the hepatic gene expression proﬁle upon ﬁpronil treatment but
other pathways may also be involved. Because the correspondingregulations were less robust, we did not further evaluate the
involvement of peroxisome proliferator-activated receptors
(PPARs) and liver X receptors (LXRs) in regulating gene expression
related to hepatic lipid metabolism in response to ﬁpronil. The aryl
Fig. 7. Functional consequences of CAR or PXR deﬁciency on internal exposure to ﬁpronil and ﬁpronil sulfone and on time-course disposition of 13C6-LT4. (A) Fipronil (light
gray) and ﬁpronil sulfone (dark gray) concentrations were assayed in plasma samples from wild-type C57BL/6J (WT, n = 11), CAR/ (n = 10) and PXR/ male mice (n = 8)
treated with ﬁpronil (3 mg/kg per day for 14 days). Signiﬁcantly different from wild-type mice: *p < 0.05. (B) 13C6-LT4 concentrations were assayed in plasma samples
collected 0.25, 2, 4, 8, 12 or 24 h after the administration of an ip bolus of 13C6-LT4 (10.2 mg/kg) to wild-type C57BL/6J, CAR/ and PXR/ mice (n = 5–10 mice/genotype/
time point) treated with ﬁpronil (dashed lines and black bars, 3 mg/kg per day for 14 days) or the vehicle alone (solid lines and white bars). 13C6-LT4 apparent clearance was
determined by pharmacokinetic analysis.
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related factor 2 (Nrf2) pathways are other important regulators of
hepatic metabolism, notably phase II conjugation [33]. As reported
previously [5] we did not observe any induction by ﬁpronil of the
typical AhR target gene Cyp1a1 in rat liver (data not shown).
Additionally, the intersections between the changes in liver gene
expression induced by ﬁpronil (our microarray data) and the
changes induced by the AhR agonist TCDD [34] or by Nrf2
activators [35] were limited to a few target genes (data not shown).
Thus, these other pathways are unlikely to play a major role, like
CAR and PXR, in mediating the effects of ﬁpronil but may still
contribute to some speciﬁc regulations.
Overall, this study represents a step further toward a better
understanding of the respective roles of the xenosensors CAR and
PXR in regulating liver gene expression, notably related to hepatic
TH metabolism. Because these receptors are modulated by
numerous species-speciﬁc ligands, including drugs and environ-
mental contaminants which could act synergically, further studiesare needed to assess their precise roles in inducing thyroid
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